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FIG. 1
PtM3 cONA sequence and corresponding amino acid sequence
1 AGAAGACAACCGAAGCACTTCTTTAAACTTATAACTTTCTCTTTCTACAAACATTTGTTG 60
61 TTCTCTCTATTATTGTTAAGGAATATGGGGAGAGGTAGAGTGGAGCTGAAGAGGATAGAG 1 2 0
M G R G R V E L K R I E
1 2 1  AACAAGATAAACAGGCAGGTGACATTTGCAAAGAGGAGAAATGGGTTGTTGAAGAAAGCT 1 8 0
N K I N R Q V T F A K R R N G L L K K A
1 8 1  TATGAGTTATCTGTGCTCTGTGATGCTGAGGTTGCTCTCATCATCTTCTCTAACCGTGGC 2 4 0
Y E L S V L C D A E V A L I  I F S N R G
2 4 1  AAGCTCTACGAGTTTTGTAGCACATCTAACATGCTGAAGACCCTGGAAAGGTATCAGAAG 3 0 0
K L Y E F C S T S N M L K T L E R Y Q K
3 0 1  TGCAGCTATGGTGCAGAAGAAGTCAATAAACCAGCCAAGGAGCTCGAGAACAGCTACAGG 3 6 0
C S Y G A E E V N K P A K E L E N S Y R
3 6 1  GAGTACTTGAAAGTGAAAGCAAGATTTGAGGGCCTACAACGAACTCAGAGGAACCTTCTT 4 2 0
E Y L K V K A R F E G L Q R T Q R N L L
4 2 1  GGAGAGGACCTCGGACCTCTGAATACCAAAGACCTTGAGCAGCTCGAGCGTCAGTTAGAG 4 8 0
G E D L G P L N T K D L E Q L E R Q L E
4 8 1  TCGTCATTGAACCAAGTTCGGTCAACTAAGACCCAGTATATGCTCGACCAACTTGCTGAT 5 4 0
S S L N Q V R S T K T Q Y M L D Q L A D
5 4 1  CTTCAAAATAAGGAACATCTGTTGCAGGAAGCTAACAGAGGTTTGACAATAAAGCTGGAT 6 0 0
L Q N K E H L L Q E A N R G L T I K L D
6 0 1  GAAATCAGTGCAAGAAATAGCCTCCGACCATCATGGGAAGGTGATGATCAGCAAAATATG 6 6 0
E I S A R N S L R P S W E G D D Q Q N M
6 6 1  TCCTACGGCCACCAGCATGCTCAGTCTCAGGGGCTATTCCAGGCTTTGGAATGCAATCCC 7 2 0
S Y G H Q H A Q S Q G L F Q A L E C N P
7 2 1  ACTTTGCAAATAGGCTACAACCCTGTTGGTTCAGACCAGGTGTCTGCAATAACACATGCC 7 8 0
T L Q I G Y W P V G S D Q V S A I T H A
7 8 1  ACCCAGCAAGTCCATGGGTTCATTCCAGGATGGATGCTTTGAGTTTTGTGCTCTTCATTG 8 4 0
T Q Q V H G F I  P G W M L *
8 4 1  CTCATAAAGGAGCACCTACCATGTAACTTTCTCTCTTGGTGTTGGTAATGTGTAAATGAT 90 0
9 0 1  TTCAAGAGCATGTGTACTTTCATTTGGACA 9 3 0
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FIG. 2
PtM4 cDNA sequence and corresponding amino acid sequence
1 GTGTGGTATATGGGGAGAGGTAGAGTGGAGCTGAAGAGGATAGAAAACAAAATTAATCGG 60  
M G R G R V E L K R I E N K I N R
6 1  CAGGTGACATTTGCAAAGAGGAGAAATGGGTTGTTGAAGAAAGCTTATGAGTTATCTGTG 1 2 0  
Q V T F A K R R N G L L K K A Y E L S V
1 2 1  CTCTGTGATGCTGAGGTTGCTCTCATCATCTTCTCTAACCGTGGCAAGCTCTACGAGTTT 1 8 0  
L C D A E V A L I  I F S N R G K L Y E F
1 8 1  TGTAGCACATCTAACATGCTGAAGACCCTGGAAAGGTATCAGAAGTGCAGCTATGGTGCA 2 4 0  
C S T S N M L K T L E R Y Q K C S Y G A
2 4 1  GAAGAAGTCAATAAACCAGCCAAGGAGCTCGAGAACAGCTACAGGGAGTACTTGAAAGTG 3 0 0  
E E V N K P A K E L E N S Y R E Y L K V
3 0 1  AAAGCAAGATTTGAGGCCCTACAACGAACTCAGAGGAACCTTCTTGGAGAGGACCTCGGA 3 6 0  
K A R F E A L Q R T Q R N L L G E D L G
3 6 1  CCTCTGAATACCAAAGATCTTGAGCAGCTCGAGCGTCAGTTAGAGTCGTCATTGAACCAA 4 2 0  
P L N T K D L E Q L E R Q L E S  S L N Q
4 2 1  GTTCGGTCAACTAAGACCCAGTATATGCTCGACCAACTTGCTGATCTTCAAAATAAGGAA 4 8 0  
V R S T K T Q Y M L D Q L A D L Q N K E
4 8 1  CATCTGTTGCTGGAAGCTAACAGAGGTTTGACAATAAAGCTGGATGAAATCAGTGCAAGA 5 4 0  
H L L L ' E A N R G L T  I  K L D E  I  S A R
5 4 1  AATAGCCTCCGACCATCATGGGAAGGTGATGATCAGCAAAATATGTCCTACGGNCACCAG 6 0 0  
N S L R P S W E G D D Q Q N M S Y G H Q
6 0 1  CACGCTCAGTCTCAGGGGCTATTCCAGGCTTTGGAATGCAATCCCACTTTGCAAATAGGC 6 6 0  
H A Q S Q G L F Q A L E C N P T L Q I G
6 6 1  TACAACGCTGTTGGTTCAGACCAGGTGTCTGCAATAACACATGCCACCCAGCAAGTCCAT 7 2 0  
Y N A V G S D Q V S A I T H A T Q Q V H
7 2 1  GGGTTCATTCCAGGATGGATGCTTTGAGTTTTGTGTTCTTCATTGCTCATAAAGGAGCAC 7 8 0  
G F I P G W M L *
7 8 1  CTACCATGTAACTTTCTCTCTTGGTGTTGGTAATGTGTAAATGATTTCAAGAGCATGTGT 8 4 0
8 4 1  ACTTTCATTTGGACATGAAAACTTTATGTGGCTGGATTTCAGAACTTTAGCCAGGGACAC 9 0 0
9 0 1  GAGGCATGTAAAAG 9 1 4
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FIG. 3
ClustalW Alignment of predicted amino acid sequences of PtM3 and PtM4
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y r e y l k v k a r f e a l q r t q r n l l g e d l g p l n t kH l e q l e r qJl e s s l n q v r s t kS q y m l d q l a d l q B k e h l l l e a n r g l t i KLDEISARNS
YREYLKVKARFEALQRTQRNLLGEDLGPLNTKflLBQLERQLLESSLNQVRSTKBQYMLDQLADLQSKEHLLLEANRGLTIKLDEISARNS 
LRPSWEGDDQQNMSYGHQHAQSQGLFQALECNPTLQIGYNHVGSE)QVSAITHATQQVHGFIPGWMLl^^MM|M^^BB|^^B 
lrpswegddqqnmsyghqhaqsqglfqalecnptlqigynIvgsdqvsaithatqqvhgfipgwivil^^^^^^^^^^^^^^^H
U.S. Patent Jun. 6, 2006 Sheet 4 of 8 US 7,057,087 B2
FIG. 4
Phylogenetic tree of predicted amino acid sequences of PtM3 (male dominant 
expression) and PtM4 (female dominant expression) compared to various 
floral and tree MADS-box sequences
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FIG. 5
PtM3 5’ untranslated region (UTR) containing PtM3 promoter and intron
sequence
2 GGCCCGGCTGGTTCTCATGTTGGACTCCGACTTTAATTACTTTAACTACAAGCTTATTAT 61
62 AATTTTTTTTTTATACTATTTTATTTCATTTCAGTATTTAAACATTATTGTTTATATAAA 1 2 1
122  AAAATAGTTGAGCCCGTGGCAAAGCATAAACCAAGACCGAATATTCTAAATACTAAATTT 1 8 1
182  CTAGTTTGTTTGATTTCTCAATGCCCCGAACAGTAACGCTGTAATCAGACAACCTCATCC 24 1
24 2  GGACAAGCCAAATCAAGAACTTTCTCCAGTATCAAACCGACACGTGGAGGAGCTCCATTT 3 0 1
302  TAAGGGAGGGGACTACTTTCTGCCACGTGTGGAAACATCTGGAAATGACAAATTGATGCC 36 1
36 2  ATATAAAATTTTCTTACATGAAAGGACCACTGTCCCTTTTTACGCCCCACCGCAGCGCGT 42 1
4 2 2  GACCACACTTACAACCCTACCTCCAACAACACTGACACAATGACCGAGACGGTGGCGCGT 4 8 1
4 8 2  GAATACACTCTCCAAACTTAGAACCTACGTTCGTAATCAATGATGTGACAAAAAAGTAAA 54 1
542  AACCAAGAAGCTTTGAAAGCTAATAAATGAATTACTATATATATTATATCAATTCTTCAA 60 1
602  GAAAATTGGAAGAAATTATTTTTTTTCAATTTAATTTATAAATATAACTATTTAATGGGG 66 1
662  AAAGACTTCTATCCTTTGGAACCTTAATTGGAAAAGCAGCAACCCCATGCCGTTAACTTG 7 2 1
72 2  AAAAAAAACGAAACCCGGGTGTATTAAAAACTTACCAACAAGGGGGTAACCTTCCACTAA 78 1
782  CCGTGTACAATGGCAAAGTAACCCAACTTAAGGAAAAAGATTCCATAAATAAAACCATTT 84 1
842 TCAAAATGTAAAATATTTTTTCAAATATTTATAAATAACTATATTAATGTGAAAGCCATC 90 1
902  ATAATCCCGATTAGGAGATACTTAATTAGGAGAAAGTCAAGTCGAGAACCCCCATTGCCG 9 6 1
962  TTAATACTTGAAAAATAAACCAGTAAAATACACAGAGGTTGCATGTAACTAGAAAGAACA 1 0 2 1
1 0 2 2  GCTAACCCTAAGCTGCATTTCTTTTCTATATATATATATATATATAACAGAAAAGAAGAA 1 0 8 1
1 0 8 2  GACAACCGAAGCACTTCTTTAAACTTATAACTTTCTCTTTCTACAAACATTTGTTGTTCT 1 1 4 1
5 'U TR  I n t r o n  ->
1 1 4 2  CTCTATTATTGGTGGGTCTTTCTTTCTCTCTAGGGTTTCTTTAAAATATCTAACTTTCTC 1 2 0 1
1 2 0 2  TTCGTTTTTCACTTATTTTGTTACAGTTTGGGTTCTGATTCCTAAAAGTGTAGATCACCT 1 2 6 1
1 2 6 2  TCTTCTTGCTCTTGAGAGAAGAACAAGAAACGAAAAAAAAAACAAAAGAAAAGGAAAGAT 1 3 2 1
1 3 2 2  ATAAAGGAAATAAAGACTAATACAAAAGTAAATATATCATTAACTTACATGGTTAGATTT 1 3 8 1
5 ' UTR I n t r o n
1 3 8 2  ATGTATTAATTATAACGAAAGATGGTTTTTTATTTGGTTTTTTTTGGCTTGTGATTATAG 1 4 4 1
144  2 TTAAGGAATATGGGGAGAGGTAGAGTGGAGCTGAAGA 14 7 8
M G R G R V E L K
A
S t a r t  c o d o n  f o r  PtM3
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FIG. 6
Flower specific mRNA expression of PtM3
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FIG. 7
Transgenic plants over-expressing PtM3
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FIG. 8
Transgenic plants containing antisense PtM3
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APPLICATION OF ASPEN MADS-BOX 
GENES TO ALTER REPRODUCTION AND 
DEVELOPMENT IN TREES
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH OR DEVELOPMENT
This invention was made with government supported 
USDA-FRA grant.
CROSS-REFERENCE TO RELATED 
APPLICATIONS
Not Applicable.
TECHNICAL FIELD
The present invention relates to the production of geneti­
cally altered plants having modified characteristics such as 
conversion of axillary meristem to floral meristem; acceler­
ated and earlier flowering; increased fruit production; 
increased nut production; increased seed output; increased 
branching; increased flower production; increased fruit 
yield; increased flower yield and combinations thereof 
obtained when the floral reproductive gene product PtM3 or 
its homolog PtM4 are over-expressed in the plant reproduc­
tive tissues. Furthermore, when the floral reproductive gene 
product PtM3 or its homolog PtM4 are under-expressed in 
a plant complete sterility; partial sterility; reduced pollen 
production, decreased flowering, increased biomass and 
combinations thereof can be obtained.
BACKGROUND OF THE INVENTION
An enormous amount of effort has been expended in 
attempts to elucidate the underlying mechanisms controlling 
flower development in various dicotyledonous plant species 
(reviewed in Coen, Annu. Rev. Plant Physiol. Plant Mol. 
Biol. 42:241-279, 1991; and Gasser, Annu. Rev. Plant 
Physiol. Plant Mol. Biol. 42:621-649, 1991), leading to the 
isolation of a family of genes which encode certain regula­
tory proteins. The most studied plant regulatory proteins 
identified to date include AGAMOUS (AG) (Yanofsky et al., 
Nature 346:35-39, 1990), APETELAI (API) (Mandel et al. 
Nature 360:273-277, 1992), and APETALA 3 (AP3) (Jack 
et al. Cell 68:683-697, 1992) in Arabidopsis thaliana, and 
DEFICIENS A (DEF A) (Sommer et al, EMBO J. 
11:251-263, 1990), GLOBOSA (GLO) (Trobner et al, 
EMBO J. 11:4693-4704, 1992), SQUAMOSA (SQUA) 
(Huijser et al, EMBO J. 11:1239-1249, 1992), and PLENA 
(PLE) (Bradley et al. Cell 72:85-95, 1993) in Antirrhinum 
majus.
Sequence analysis of these plant regulatory genes has 
revealed that their gene products contain a conserved 
MADS-box region (Bradley et al. Cell 72:85-95, 1993; 
Huijser et al, EMBO J. 11:1239-1249, 1992; Jack et al. 
Cell 68:683-697, 1992; Mandel et al. Nature 360:273-277, 
1992; Sommer et al, EMBO J. 11:251-263, 1990; Trobner 
et al, EMBO J. 11:4693-4704, 1992; Yanofsky et al. Nature 
346:35-39, 1990). Transgenic approaches have been 
employed to study the functional roles of MADS-box genes 
(Kempin et al. Plant Physiol. 103:1041-1046, 1993; Man- 
del et al. Cell 71:133-143, 1992). MADS-box genes have 
been found to play an important role in specifying floral 
meristems and floral oigan identity in plants such as Ara­
bidopsis (Yanofsky et al. The Plant Cell, 7:721-733, 1995). 
Furthermore, using conserved MADS-box regions as
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probes, MADS-box genes have been isolated from other 
species including tomato (Mandel et al. Cell 71:133-143, 
1992), tobacco (Kempin et al. Plant Physiol. 
103:1041-1046, 1993), petunia (Angenent et al. Plant Cell 
4:983-993, 1992), Brassica napus (Mandel et al. Cell 
71:133-143, 1992), and maize (Schmidt et al. Plant Cell 
5:729-737, 1993).
However, very few MADS-box genes have been cloned 
from tree species. MADS-box genes were recently found in 
spruce trees to encode transcription factors, which are key 
components in the developmental control systems of coni­
fers, such as the identity of the floral organs (Tandre, et al. 
The Plant Journal 15(5), 615-623, 1998). Also, recently 
another MADS-box gene, a DEFICIENS homolog and its 
promoter were isolated from the dioecious tree, black cot­
tonwood and were found to regulate expression in female 
and male floral meristems of the two-whorled, unisexual 
flowers (Strauss et al. Plant Physiology 124:627-639, 
2000).
In addition, genetic engineering is slowly showing poten­
tial for the improvement of qualitative and quantitative traits 
in plants and trees. However, the full potential of transgenic 
plants can not be realized until methods can be developed to 
restrict or eliminate long distance migration of seeds and 
pollen from transgenic plants. Accordingly, to facilitate the 
production of genetically engineered trees, it is desirable that 
the trees be completely reproductively sterile. The ability to 
produce sterile transgenic trees is very desirable because 
there is a high potential for escape of transgenes in trees into 
wild populations due to their long distance movement of 
seeds, pollen, and their ubiquitous wild relatives. Engineer­
ing total male and female sterility for gene containment and 
other desired traits or partial sterility for selective breeding 
as discussed herein below is an important characteristic for 
transgenic plants to possess. It would therefore be highly 
desirable to have means to affect complete or partial repro­
ductive sterility. The present invention satisfies this need and 
provides related advantages as well.
Also, timing of the transition from vegetative growth to 
flowering is one of the most important steps in plant devel­
opment. This determines quality and quantity of most crop 
species since the transition determines the balance between 
vegetative and reproductive growth. It would therefore be 
highly desirable to have means to affect the timing of this 
transition so that flowering time can be controlled resulting 
in earlier flowering and conversion of axillary meristems to 
floral meristems.
Furthermore, traditionally, plant breeding involves gen­
erating hybrids of existing plants, which are examined for 
improved yield or quality. The improvement of existing 
plant crops through plant breeding is central to increasing 
the amount of food grown in the world since the amount of 
land suitable for agriculture is limited. For example, the 
development of new strains of crops, fruit and nuts through 
plant breeding has increased the yield of these crops grown 
in underdeveloped countries. Unfortunately, plant breeding 
is inherently a slow process since plants must be reproduc­
tively mature before selective breeding can proceed. For 
some plant species, the length of time needed to mature to 
flowering is so long that selective breeding, which requires 
several rounds of backcrossing progeny plants with their 
parents, is impractical. For example, some trees do not 
flower for several years after planting. It would therefore be 
highly desirable to have means to affect breeding of such 
plant species for a variety of different economically valuable 
or aesthetically pleasing traits.
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SUMMARY OF THE INVENTION
The present invention provides compositions and meth­
ods for producing transgenic plants with altered character­
istics by increasing the PtM3 promoter activity, or a func­
tionally equivalent fragment of the PtM3 promoter, 
increasing expression of the PtM3 protein, or a functionally 
equivalent fragment of the PtM3 protein sequence, and 
combinations thereof, the resulting transgenic plants com­
prising at least one of the following plant characteristics 
which include the ability to convert axillary meristem to 
floral meristem; to produce accelerated flowering, i.e., ear­
lier flowering, to increase fruit production; to increase nut 
production; to increase seed output; to increase branching; to 
increase flower production; to increase fruit yield; and to 
increase flower yield.
The present invention also provides compositions and 
methods for producing transgenic plants by suppressing the 
PtM3 promoter activity or a functionally equivalent frag­
ment of the PtM3 promoter; suppressing expression of the 
PtM3 protein or a functionally equivalent fragment of the 
PtM3 protein sequence; expressing a known cytotoxic gene 
product under the transcriptional control of the PtM3 pro­
moter or a functionally equivalent fragment of the PtM3 
promoter; and combinations thereof, the resulting transgenic 
plants comprising either complete sterility or partial sterility; 
and wherein at least one of the effects of the sterility is 
reduced pollen production; decreased flowering; increased 
biomass and combinations thereof.
The present invention further provides compositions and 
methods for producing sterile transgenic plants, by suppress­
ing the PtM3 promoter activity or a functionally equivalent 
fragment of the PtM3 promoter; suppressing expression of 
the PtM3 protein or a functionally equivalent fragment of 
the PtM3 protein sequence; expressing a known cytotoxic 
gene product under the transcriptional control of the PtM3 
promoter or a functionally equivalent fragment of the PtM3 
promoter; and combinations thereof, wherein additional 
exogenous nucleotide sequences that alter plant character­
istics may be introduced into the genome of the plant, and 
wherein the altered plant characteristic includes at least one 
of increased wood quality, increased growth, increased 
pesticide resistance, increased herbicide resistance, and 
combinations thereof .
The present invention also provides kit for producing 
transgenic plants by increasing the PtM3 promoter activity, 
or a functionally equivalent fragment of the PtM3 promoter, 
increasing expression of the PtM3 protein, or a functionally 
equivalent fragment of the PtM3 protein sequence, and 
combinations thereof, the resulting transgenic plants com­
prising at least one of the following plant characteristics 
which include the ability to convert axillary meristem to 
floral meristem; to produce accelerated flowering, i.e., ear­
lier flowering; to increase fruit production; to increase nut 
production; to increase seed output; to increase branching; to 
increase flower production; to increase fruit yield; and to 
increase flower yield, wherein the kit may include the 
following components: a purified antibody to at least one of 
PtM3 and PtM4 proteins or functionally equivalent frag­
ments thereof, gene constructs containing at least a promoter 
(i.e., either constitutive, tissue-specific, or temporal-spe­
cific) and a coding region, containing the PtM3 polypeptide 
or a functionally equivalent fragments thereof, host cells, 
and appropriate controls.
The present invention provides kit for producing trans­
genic plants by suppressing the PtM3 promoter activity or a 
functionally equivalent fragment of the PtM3 promoter;
3
suppressing expression of the PtM3 protein or a functionally 
equivalent fragment of the PtM3 protein sequence; express­
ing a known cytotoxic gene product under the transcriptional 
control of the PtM3 promoter or a functionally equivalent 
fragment of the PtM3 promoter; and combinations thereof, 
resulting in transgenic plants that may comprise either 
complete sterility or partial sterility; wherein at least one of 
the effects of the sterility is reduced pollen production; 
decreased flowering; increased biomass and combinations 
thereof; wherein the kit may include the following compo­
nents: a purified antibody to at least one of PtM3 and PtM4 
proteins or functionally equivalent fragments thereof, gene 
constructs containing at least a promoter (i.e., either consti­
tutive, tissue-specific, or temporal-specific) and a coding 
region, containing the PtM3 polypeptide or a functionally 
equivalent fragments thereof, host cells, and appropriate 
controls.
The present invention provides kit for producing sterile 
transgenic plants by suppressing the PtM3 promoter activity 
or a functionally equivalent fragment of the PtM3 promoter; 
suppressing expression of the PtM3 protein or a functionally 
equivalent fragment of the PtM3 protein sequence; express­
ing a known cytotoxic gene product under the transcriptional 
control of the PtM3 promoter or a functionally equivalent 
fragment of the PtM3 promoter; and combinations thereof, 
wherein additional exogenous nucleotide sequences that 
alter plant characteristics may be introduced in the genome 
of the plant, wherein the altered plant characteristic includes 
at least one of increased wood quality, increased growth, 
increased pesticide resistance, increased herbicide resis­
tance, and combinations thereof; wherein the kit may 
include the following components: a purified antibody to at 
least one of PtM3 and PtM4 proteins or functionally equiva­
lent fragments thereof, gene constructs containing at least a 
promoter (i.e., either constitutive, tissue-specific, or tempo­
ral-specific) and a coding region, containing the PtM3 
polypeptide or a functionally equivalent fragments thereof, 
host cells, and appropriate controls.
The present invention also provides a method of growing 
trangenically engineered plants in space. Plants grown extra- 
terrestrially are insensitive to photoperiod and temperature 
for flowering. Transgenic plants carrying the PtM3 gene 
would be expected to flower in the extremely abnormal 
growth conditions found in a space shuttle or space station.
The patents, references and articles cited herein are 
hereby fully incorporated by reference. In the case of 
conflict between the present disclosure and the incorporated 
patents, references and articles, the present disclosure should 
control.
The foregoing and other aspects of the invention will 
become more apparent from the following detailed descrip­
tion and accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 illustrates the polynucleotide (SEQ ID NO:l) 
sequence and amino acid (SEQ ID NO:4) sequence of Aspen 
PtM3.
FIG. 2 illustrates the polynucleotide (SEQ ID NO:2) 
sequence and amino acid (SEQ ID NO:5) sequence of Aspen 
PtM4.
FIG. 3 illustrates the predicted amino acid sequence 
alignment between Aspen PtM3 (SEQ ID NO: 4) and Aspen 
PtM4 (SEQ ID NO: 5), wherein the sequence identity 
between the two homologs is 97% using the Clustal W 
sequence alignment algorithm. Clustal W is a general pur­
pose multiple sequence alignment program for DNA or
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proteins. It produces biologically meaningful multiple 
sequence alignments of divergent sequences. It calculates 
the best match for the selected sequences, and lines them up 
so that the identities, similarities and differences can be seen. 
Details of algorithms, implementation and useful tips on 
usage of Clustal programs can be found in the following 
publications; Jeanmougin, F., Thompson, J. D., Gouy, M., 
Higgins, D. G. and Gibson, T. J. (1998) Multiple sequence 
alignment with Clustal X. Trends Biochem Sci, 23, 403-5. 
Thompson, J. D., Gibson, T. J., Plewniak, F., Jeanmiougin, 
F. and Higgins, D. G. (1997) The Clustal X windows 
interface: flexible strategies for multiple sequence alignment 
aided by quality analysis tools. Nucleic Acids Research, 
24:4876^1882. Higgins, D. G., Thompson, J. D. and Gibson, 
T. J. (1996) Using CLUSTAL for multiple sequence align­
ments. Methods Enzymol., 266, 383^102.
FIG. 4 illustrates the phylogenetic tree of predicted amino 
acid sequences of PtMl, PtM2, PtM3 (male dominant 
expression) and PtM4 (female dominant expression) com­
pared to various floral and tree MADS-box sequences. The 
phylogenetic tree including several MADS-box genes is 
shown in FIG. 4, indicating that PtM3 and PtM4 occupy a 
separate branch and are not identical to Arabidopsis AGL 
(Sepallata) genes. The phylogenetic analysis was obtained 
by heuristic search algorithms using the PAUP (Phyloge­
netic Analysis Using Parsimony) version 4.0 beta 4a soft­
ware tool for comparative biological sequence analysis. 
Starting with a set of aligned sequences, a search was 
performed for phylogenetic trees that were optimal (standard 
default parameters may be applied). Heuristic search analy­
sis was done on sequence alignments followed by Bootstrap 
analysis using 100 replicates. Branch numbers refer to the 
number of replicates that support the branch. Accession 
numbers of sequences and names of plant species are 
provided immediately below:
[Populus tremuloides] PTM1; PTM2; PtM3; PtM4: [Popu- 
lus balsamifera subsp. trichocarpa\ PtAG2, 
AAC06238.1; PtAGl, AAC06237.1; PtD, AAC13695.2; 
[Antirrhinum majus] DEFA, S12378; GLO, Q03416; 
SQUA, S20886; DEFH125, T17029; DEFH72, S71756; 
DEFH49, S78015; [Arabidopsis thaliana] AG, P17839; 
AGL1/SHP1, CAB88295; AGL2/SEP1, T51409; AGL3, 
S57793; AGL4/SEP2, D39534; AGL5, E39534; AGL6, 
F39534; AGL8, S71208; AGL9/SEP3, T00656; AGL11, 
T04000; AGL12, AAF23331; AGL13, T47904; AGL14, 
T09347; AGL15, S71200; AGL17, T05621; AGL18, 
AAG37900; AGL 19, AAG37901; AGL20, AAG16297; 
AGL24, T05580; AGL27-I, AAG37902; AGL27-II, 
AAG37903; AGL29, T02331; AGL31, AAG37904; API/ 
AGL7, P35631; AP3, A42095; PI, A53839; [Brassica 
napus] AGL15-1, T07867; AGL15-2, T07869; [Eucalyp­
tus grandis] EGM1, AAC78282; EGM2, AAC78283; 
EGM3, AAC78284; EAP2L, AAG30923; EAP2S,
AAG27459; EAP1, AAG24909; [Malus domestical] 
MDM1, AAC25922; MDM2, AAC83170; MDM3,
AAD51422; MDM4, AAD51423; MDM5, CAA04321; 
MDM6, CAA04322; MDM7, CAA04324; MDM8,
CAA04919; MDM9, CAA04920; MDM10, CAA04324; 
[Petunia hybrida] PAG, Q40885; FBP1, JQ1689; FBP2, 
JQ1690; TM6, AAF73933: [Nicotiana tabacum] NtDEF, 
CAA65288; NtGLO, Q03416; NtMl, S46526; NtM4, 
AAF76381; NtM5, AAD39035; NtAGl, Q43585; [Lyco- 
persicon esculentum] TAG1, T07185; TDR3, S23729; 
TDR5, CAA43170; TDR6, S23731.
FIG. 5 illustrates the polynucleotide sequence of the PtM3 
Promoter (SEQ ID NO: 3) along with the 5'-untranslated 
region (UTR) and intron sequence. The PtM3 promoter (See
5
bolded sequence from 1153 to 1441) contains a MADS-box 
sequence motif, which is believed to regulate gene expres­
sion by binding to sites, known as CArG boxes, TATA 
sequences, etc., present in the promoter regions of plant 
MADS-box genes (Riechmann et ah, Biol. Chem. 378: 
1079-1101 (1998).
FIG. 6 illustrates the flower specific mRNA expression of 
PtM3 and PtM4. RNA (10 pg) from each developmental 
stage of female aspen flowers was fractionated on a 1.2% 
formaldehyde agarose gel and transferred to Hybond™ 
N-nylon membranes (purchased from Amersham). The blot 
was hybridized to 32P-labeled probe at 68° C. and washed at 
high stringency. The specific 3'UTR of PtM3 was used as a 
probe. Panel A shows expression of PtM3 mRNA at specific 
flower bud developmental stages, as compared to control 
tissues (leaf and xylem RNA). Panel B shows expression of 
PtM4 mRNA at specific flower bud developmental stages, as 
compared to control tissues (leaf and xylem RNA). Panel C 
shows the differential expression of male PtM3 (M) and 
female (F) PtM4 floral buds from stage 4 as compared to leaf 
(L) and xylem (X) RNA. Panel D shows the result of having 
the 3'-UTR probe of PtM3 used to hybridize against total 
RNA from Stage 4 male and female buds.
FIG. 7 illustrates the various phenotypes of transgenic 
plants over-expressing PtM3. Panel A, shows a tobacco 
plant from transgenic line PtM3-21 (right) displaying early 
flowering and conversion of axillary meristems to floral 
meristems as compared to a WT tobacco plant (left). Panel 
B, shows a T1 generation plant from one control construct 
from line pTCS5. Panel C, shows a T1 generation plant from 
transgenic line PtM3-9-9. Panel D, shows a T3 generation 
transgenic Arabidopsis from line PtM3-4-3 (right) display­
ing increased branching and flower pod production as com­
pared to WT (left). Panel E, shows a graph depicting the 
average seed yields (mg) in the transgenic PtM3-4-3 plants 
(right) as compared to WT (left).
FIG. 8 illustrates transgenic plants containing antisense 
PtM3. In panel A, the control is flowering. In panel B, the 
antisense PtM3 tobacco plant is not flowering; in fact, the 
antisense PtM3 transgenic plants mature and begin senesc- 
ing and eventually die without flowering. Panel C shows a 
transgenic tobacco plant containing inverted repeats of part 
of the PtM3 sequence which does not form flowers, in 
comparison to the control plants that form normal flowers 
(panel D). Panels E and F show the absence of petals and 
stamens when an inverted repeat of male PtM3 is introduced 
into the bisexual tobacco plant. Only female sex organs are 
formed and may be pollinated by pollen from a control to 
form pods. This shows that the PtM3 may also have a role 
in the male sex determination. Panel G shows flowerless 
Arabidopsis terminal and Panel H shows normal pod devel­
opment in the control plant.
DETAILED DESCRIPTION OF THE 
INVENTION
The present invention provides compositions, methods, 
and kits for producing transgenic plants with a number of 
desirable plant characteristics. Before one can appreciate the 
altered plant characteristics provided herein, more detailed 
knowledge of the invention may be desired and follows.
A flower, like a leaf or shoot, is derived from the shoot 
apical meristem, which is a collection of undifferentiated 
cells set aside during embryogenesis. The production of 
vegetative structures, such as leaves or shoots, and of 
reproductive structures, such as flowers, is temporally seg­
regated, such that a leaf or shoot arises early in a plant life
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cycle, while a flower develops later. The transition from 
vegetative to reproductive development is the consequence 
of a process termed floral induction (Yanofsky, Ann. Rev. 
Plant Physiol. Plant Mol. Biol. 46:167-188 (1995), which is 
incorporated herein by reference).
Once induced, shoot apical meristem either persists and 
produces floral meristem, which gives rise to flowers, and 
lateral meristem, which gives rise to branches, or is itself 
converted to floral meristem. Floral meristem differentiates 
into a single flower having a fixed number of floral organs 
in a whorled arrangement. Dicots, for example, contain four 
whorls (concentric rings), in which sepals (first whorl) and 
petals (second whorl) surround stamens (third whorl) and 
carpels (fourth whorl).
Although shoot meristem and floral meristem both consist 
of meristemic tissue, shoot meristem is distinguishable from 
the more specialized floral meristem. Shoot meristem gen­
erally is indeterminate and gives rise to an unspecified 
number of floral and lateral meristems. In contrast, floral 
meristem is determinate and gives rise to the fixed number 
of floral organs that comprise a flower.
Genetic studies have identified a number of genes 
involved in regulating flower development. These genes can 
be classified into different groups depending on their func­
tion. Flowering time genes, for example, are involved in 
floral induction and regulate the transition from vegetative to 
reproductive growth. In comparison, the floral meristem 
identity genes, which are the subject matter of the present 
invention as disclosed herein, encode proteins that promote 
the conversion of shoot meristem to floral meristem in an 
angiosperm. In addition, floral organ identity genes encode 
proteins that determine whether sepals, petals, stamens or 
carpels are formed during floral development (Yanofsky, 
supra, 1995; Weigel, Ann. Rev. Genetics 29:19-39 (1995), 
which is incorporated herein by reference). Some of the 
floral meristem identity gene products also have a role in 
specifying floral oigan identity.
Many floral identity genes may be characterized as plant 
MADS box genes. The plant MADS box genes generally 
encode proteins of about 260 amino acids including a highly 
conserved MADS domain of about 56 amino acids (Riech- 
mann and Meyerowitz, Biol. Chem. 378:1079-1101 (1997), 
which is incorporated herein by reference). The MADS 
domain, which was first identified in the Arabidopsis AGA- 
MOUS and Antirrhimum majus DEFICIENS genes, is con­
served among transcription factors found in humans (serum 
response factor; SRF) and yeast (MCM1; Norman et ah, Cell 
55:989-1003 (1988); Passmore et al., J. Mol. Biol. 204: 
593-606 (1988), and is the most highly conserved region of 
the MADS domain proteins. The MADS domain is the 
major determinant of sequence specific DNA-binding activ­
ity and can also perform dimerization and other accessory 
functions (Huang et al., The Plant Cell 8:81-94 (1996)). The 
MADS domain frequently resides at the N-terminus, 
although some proteins contain additional residues at the 
N-terminus to the MADS domain.
The “intervening domain” or “I-domain,” located imme­
diately at the C-terminus to the MADS domain, is a weakly 
conserved domain having a variable length of approximately 
30 amino acids (Purugganan et al., Genetics 140:345-356 
(1995)). In some proteins, the I-domain plays a role in the 
formation of DNA-binding dimers. A third domain present 
in plant MADS domain proteins is a moderately conserved 
70 amino acid region denoted the “keratin-like domain” or 
“K-domain.” Named for its similarity to regions of the 
keratin molecule, the structure of the K-domain appears 
capable of forming amphipathic helices and may mediate
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protein-protein interactions (Ma et al., Genes Devel. 
5:484-495 (1991)). The most variable domain, both in 
sequence and in length, is the carboxy-terminal or “C-do- 
main” of the MADS domain proteins. Dispensable for DNA 
binding and protein dimerization in some MADS domain 
proteins, the function of this C-domain remains unknown.
The term “ectopically expressible” is used herein to refer 
to a nucleic acid molecule encoding a floral reproductive 
gene product that can be expressed in a tissue other than a 
tissue in which it normally is expressed or at a time other 
than the time at which it normally is expressed, provided that 
the floral reproductive gene product is not expressed from its 
native, naturally occurring promoter. Ectopic expression of 
a floral reproductive gene product is a result of the expres­
sion of the gene coding region from a heterologous promoter 
or from a modified variant of its own promoter, such that 
expression of the floral reproductive gene product is no 
longer in the tissue in which it normally is expressed or at 
the time at which it normally is expressed. An exogenous 
nucleic acid molecule encoding a PtM3 or PtM4 gene 
product under the control of its native, wild type promoter, 
for example, does not constitute an ectopically expressible 
nucleic acid molecule encoding a floral reproductive gene 
product. However, a nucleic acid molecule encoding an 
PtM3 or PtM4 gene product under the control of a consti­
tutive promoter, which results in expression of PtM3 or 
PtM4 in a tissue such as shoot meristem where it is not 
normally expressed, is an ectopically expressible nucleic 
acid molecule as defined herein.
Actual ectopic expression of a floral reproductive gene is 
dependent on various factors and can be constitutive, tissue- 
specific, temporal specific or inducible expression. For 
example, PtM3 or PtM4, which normally may be expressed 
in floral meristem, may be ectopically expressible in the 
terminal axillary meristem of a plant, such as an angiosperm. 
As disclosed herein, when a floral reproductive gene product 
such as PtM3 or PtM4 is ectopically expressed in floral 
meristem of a plant, such as in an angiosperm, the axillary 
meristem is converted to floral meristem and early repro­
ductive development occurs.
As disclosed herein, an ectopically expressible nucleic 
acid molecule encoding a floral reproductive gene product 
can be, for example, a transgene encoding a floral repro­
ductive gene product under the control of a heterologous 
gene regulatory element. In addition, such an ectopically 
expressible nucleic acid molecule may be an endogenous 
floral reproductive gene coding sequence that is placed 
under the control of a heterologous gene regulatory element. 
The ectopically expressible nucleic acid molecule also may 
be, for example, an endogenous floral reproductive gene 
having a modified gene regulatory element such that the 
endogenous floral reproductive gene is no longer subject to 
negative regulation by a transcription factor.
Also, an ectopically expressible nucleic acid molecule 
encoding a floral reproductive gene product can be 
expressed, as desired, either constitutively or inducibly. 
Such an ectopically expressible nucleic acid molecule 
encoding a floral reproductive gene product can be an 
endogenous floral reproductive gene that has, for example, 
a mutation in a gene regulatory element. An ectopically 
expressible nucleic acid molecule encoding a floral repro­
ductive gene product also can be an endogenous nucleic acid 
molecule encoding a floral reproductive gene product that is 
linked to an exogenous, heterologous gene regulatory ele­
ment that confers ectopic expression. In addition, an ectopi­
cally expressible nucleic acid molecule encoding a floral 
reproductive gene product can be an exogenous nucleic acid
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molecule that encodes a floral reproductive gene product 
under control of a heterologous gene regulatory element.
As used herein, the term “transgenic” refers to a plant or 
a tree that contains in its genome an exogenous nucleic acid 
molecule, which can be derived from the same or a different 
plant species. The exogenous nucleic acid molecule can be 
a gene regulatory element such as a promoter, enhancer or 
other regulatory element or can contain a coding sequence, 
which can be linked to a heterologous gene regulatory 
element.
The term “tree” encompasses any tree and progeny 
thereof. The term also encompasses parts of trees, including 
seed, cuttings, tubers, fruit, flowers, etc. A list of non­
limiting examples of trees to which the invention may apply 
include hardwood trees such as Populus species, cotton­
woods, Sweetgum, or eucalyptus and fruit trees such as 
apple, peach, nut trees such as walnuts, pecans or almonds.
The term “plant” encompasses any plant and progeny 
thereof. The term also encompasses parts of plants, includ­
ing seed, cuttings, tubers, fruit, flowers, etc. The term 
“plant” also includes whole plants and portions of plants, 
including plant organs (e.g., roots, stems, leaves, etc). A list 
of non-limiting examples of plants to which the invention 
may apply include herbaceous plants (e.g., Arabidopsis, 
asparagus and tobacco) and crop plants (e.g., Common bean 
(.Phaseolus vulgaris), Maize or corn (Zea mays), Pea (Pisum 
sativum), Squashes (Cucurbita spp.), Potato (Solarium spp.), 
Tomato (Lycopersicon esculentum), Groundnut or peanut 
(.Arachis hypogaea), Wheat (Triticum spp.), Barley (Plor- 
deum vulgare), Sunflower (,Helianthus annuus), Peppers 
(iCapsicum annuum), Sorghum (Sorghum bicolor), Rice 
(Oryza sativa), Banana & plantain (Musa spp. ), Cotton 
(Gossypium spp.), Cabbages, turnips, etc. (Brassica spp.), 
Soybean (Glycine max), Lentil (Lens culinaris) Alfalfa 
(.Medicago sativa), Field bean (Vicia faba), Cowpea (Cigna 
unguiculata), Coconut (Cocos nucifera), Lettuce (Lactuca 
sativa), Walnut (Juglans spp.), Melon and cucumber (Cucu- 
mis spp.) Almonds and peaches (Prunus spp.), Olive (Olea 
europea), Grape (Vitis spp.), Citrus (Citrus spp.), Cassava 
(Manihot esculentum), Sugarcane (Saccharum spp.), Pigeon 
pea (Cajanus cajan), Chickpea or garbanzo (Cicer arieti- 
num), Oat (Avena sativa spp.), Flax (Linum usitatissimum), 
and Coffee (Coffea arabica).
As used herein, the term “floral gene product” means a 
gene product (i.e., a polypeptide) that, for example, pro­
motes conversion of axillary meristem to floral meristem in 
a plant e.g., an angiosperm, such as PtM3, homologs, 
orthologs or functionally equivalent fragments thereof. As 
disclosed herein in Example 5, expression of a floral repro­
ductive gene product such as PtM3 can convert axillary 
meristem to floral meristem, promote early reproductive 
development, increase branching, increase flower pod pro­
duction, and increase seed yields in an angiosperm.
Floral genes in particular are conserved among distantly 
related angiosperm and gymnosperm species. The conser­
vation of floral gene products in non-flowering plants such 
as coniferous trees indicates that floral meristem genes can 
promote the reproductive development of gymnosperms as 
well as angiosperms.
As used herein, the term “seed plant” means an 
angiosperm or gymnosperm. An angiosperm is a seed­
bearing plant whose seeds are borne in a mature ovary 
(fruit). Angiosperms are divided into two broad classes 
based on the number of cotyledons, which are seed leaves 
that generally store or absorb food. Thus, a monocotyledon- 
ous angiosperm is an angiosperm having a single cotyledon, 
and a dicotyledonous angiosperm is an angiosperm having
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two cotyledons. Angiosperms are well known and produce 
a variety of useful products including materials such as 
lumber, rubber, and paper; fibers such as cotton and linen; 
herbs and medicines such as quinine and vinblastine; orna­
mental flowers such as roses and orchids; and foodstuffs 
such as grains, oils, fruits and vegetables.
Angiosperms encompass a variety of flowering plants, 
including, for example, cereal plants, herbaceous plants 
(such as for example tobacco plants or Arabidopsis plants, 
etc.), crop plants, perennial plants, seed plants, leguminous 
plants, oilseed plants, hardwood trees, fruit-bearing plants, 
and ornamental flowers, which general classes are not nec­
essarily exclusive. Cereal plants, which produce an edible 
grain cereal, include, for example, com, rice, wheat, barley, 
oat, rye, orchardgrass, guinea grass, sorghum and turfgrass. 
In addition, a leguminous plant is an angiosperm that is a 
member of the pea family (Fabaceae) and produces a char­
acteristic fmit known as a legume. Examples of leguminous 
plants include, for example, soybean, pea, chickpea, moth 
bean, broad bean, kidney bean, lima bean, lentil, cowpea, 
dry bean, and peanut. Examples of legumes also include 
alfalfa, birdsfoot trefoil, clover and sainfoin. An oilseed 
plant also is an angiosperm with seeds that are useful as a 
source of oil. Examples of oilseed plants include soybean, 
sunflower, rapeseed and cottonseed. The skilled artisan will 
recognize that the methods of the invention can be practiced 
using these or other angiosperms, as desired.
An angiosperm also can be a hardwood tree, which is a 
perennial woody plant that generally has a single stem 
(trunk). Examples of such trees include alder, ash, aspen, 
basswood (linden), beech, birch, cherry, cottonwood, elm, 
eucalyptus, hickory, locust, maple, oak, persimmon, poplar, 
sweetgum, sycamore, pecans, almonds, walnut and willow. 
Other trees that are encompassed by this invention are 
dioecious trees (sexes are on different trees), hybrid trees, 
bisexual trees (both female and male sexes are located on 
one tree), and pollen producing trees. Trees are useful, for 
example, as a source of pulp, paper, structural material, fuel 
and for maintaining biodiverse forestry in an urban setting 
(i.e., urban forestry).
An angiosperm also can be a fruit-bearing plant, which 
produces a mature, ripened ovary (usually containing seeds) 
that is suitable for human or animal consumption. For 
example, hops used for their flavoring in malt liquor are a 
member of the mulberry family. Fruit-bearing angiosperms 
also include grape, orange, lemon, grapefruit, avocado, date, 
peach, cherry, olive, plum, coconut, apple and pear trees and 
blackberry, blueberry, raspberry, strawberry, pineapple, 
tomato, cucumber and eggplant plants. An ornamental 
flower is an angiosperm cultivated for its decorative flower. 
Examples of commercially important ornamental flowers 
include rose, orchid, lily, tulip and chrysanthemum, snap­
dragon, camellia, carnation and petunia plants. The skilled 
artisan will recognize that the methods of the invention can 
be practiced using these, other angiosperms, or hybrid plants 
or hybrid trees thereof, as desired.
The term “gymnosperm” refers to plants that produce 
naked seeds, i.e., seeds that are not encased in an ovary. A 
specific example of a gymnosperm is Pinus taeda (L.) 
[loblolly pine]. Gymnosperms encompass four classes: 
cycads, ginkgo, conifers and gnetophytes. The conifers are 
the most widespread of living gymnosperms and frequently 
are cultivated for structural wood or for pulp or paper. 
Conifers include redwood trees, pines, firs, spruces, hem­
locks, Douglas firs, cypresses, junipers and yews. The 
skilled artisan will recognize that the methods of the inven­
10
5
10
15
20
25
30
35
40
45
50
55
60
65
US 7,057,087 B2
tion can be practiced with these, other gymnosperms, or 
hybrid plants or hybrid trees thereof, as desired.
The term “dioecious tree” refers to trees having male 
reproductive oigans in one tree and female in another (i.e., 
the female and male reproductive organs are on different 
trees). Also, the staminate and the pistillate flowers are borne 
on different trees.
As used herein, the term “introducing,” when used in 
reference to a nucleic acid molecule and a seed plant such as 
an angiosperm or a gymnosperm, means transferring an 
exogenous nucleic acid molecule into the seed plant. For 
example, an exogenous nucleic acid molecule encoding a 
floral reproductive gene product can be introduced into a 
seed plant by a variety of methods including Agrobacterium- 
mediated transformation or direct gene transfer methods 
such as electroporation or microprojectile-mediated trans­
formation.
The term “transformation” refers to the transfer of a 
foreign gene into the genome of a host organism and its 
genetically stable inheritance.
Transformation methods based upon the soil bacterium 
Agrobacterium tumefaciens, known as “agro-infection,” are 
useful for introducing a nucleic acid molecule into a broad 
range of angiosperms and gymnosperms. The wild type form 
of Agrobacterium contains a Ti (tumor-inducing) plasmid 
that directs production of tumorigenic crown gall growth on 
host plants. Transfer of the tumor-inducing T-DNA region of 
the Ti plasmid to a plant genome requires the Ti plasmid- 
encoded virulence genes as well as T-DNA borders, which 
are a set of direct DNA repeats that delineate the region to 
be transferred. Agrobacterium-based vector is a modified 
form of a Ti plasmid, in which the tumor-inducing functions 
are replaced by nucleic acid sequence of interest to be 
introduced into the plant host.
Current protocols for Agrobacterium-mediated transfor­
mation employ cointegrate vectors or, suitably, binary vector 
systems in which the components of the Ti plasmid are 
divided between a helper vector, which resides permanently 
in the Agrobacterium host and carries the virulence genes, 
and a shuttle vector, which contains the gene of interest 
bounded by T-DNA sequences. A variety of binary vectors 
are well known in the art and are commercially available 
from, for example, Clontech (Palo Alto, Calif.). Methods of 
coculturing Agrobacterium with cultured plant cells or 
wounded tissue such as leaf tissue, root explants, hypocoty- 
ledons, stem pieces or tubers, for example, also are well 
known in the art (Click and Thompson (eds.), Methods in 
Plant Molecular Biology and Biotechnology, Boca Raton, 
Fla.: CRC Press (1993), which is incorporated herein by 
reference). Wounded cells within the plant tissue that have 
been infected by Agrobacterium can develop oigans de novo 
when cultured under the appropriate conditions; the result­
ing transgenic shoots eventually give rise to transgenic 
plants containing the exogenous nucleic acid molecule of 
interest.
Agrobacterium-mediated transformation has been used to 
produce a variety of transgenic seed plants (see, e.g., Wang 
et al. (eds), Transformation of Plants and Soil Microorgan­
isms, Cambridge, UK: University Press (1995), which is 
incorporated herein by reference). For example, Agrobacte­
rium-mediated transformation can be used to produce trans­
genic crudiferous plants such as Arabidopsis, mustard, rape- 
seed and flax; transgenic leguminous plants such as alfalfa, 
pea, soybean, trefoil and white clover; and transgenic 
solanaceous plants such as eggplant, petunia, potato, 
tobacco and tomato. In addition, Agrobacterium-mediated 
transformation can be used to introduce exogenous nucleic
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acids into apple, aspen, belladonna, black currant, carrot, 
celery, cotton, cucumber, grape, horseradish, lettuce, morn­
ing glory, muskmelon, neem, poplar, strawberry, sugar beet, 
sunflower, walnut and asparagus plants (see, for example, 
Glick and Thompson, supra, 1993). Furthermore, methods 
for generating transgenic plants such as Aspen are known to 
those skilled in the art and can be readily found in the 
following references: Boeijan W, Baucher M, Chabbert B, 
Petit-Conil M, Leple J C, Pilate G, Cornu D, Monties B, Inze 
D, Van Doorsselaere J, Jouanin L and Van Monatgu M, with 
Tsai C-J, Podila G K and Chiang V L (1997) Genetic 
modification of lignin biosynthesis in quaking aspen and 
poplar. In: Klopfenstein NB, Chun Y W, Kim M S, Ahuja M 
R, eds Dillon, M C, Carman R C, Eskew L G, tech eds. 
Micropropagation, genetic engineering and molecular biol­
ogy of Populus. Gen. Tech. Rep RM-GTR-297. Fort Collins, 
Colo.: USDA, Forest Service, Rocky Mountain research 
station, pp 193-205; Kamosky, D. F., B. Sen, J. Kim, B. 
Xiang, X. Lu, L. Cseke, D. Dixon, J. J. Liu, G. Wyckofif, and 
Gopi K. Podila. 2000; Engineering reproductive sterility in 
forest trees. Proc. International Workshop BIO-REFOR. 
Nepal, 1999. pp. 7-11; Genetic engineering of Populus 
species to improve resistance to environmental stresses; 
Tsai, C. J., Podila, G. K. and Chiang, V. L., (1994) Agro­
bacterium-mediated transformation of quaking aspen 
(Populus tremuloides) and regeneration of transgenic plants. 
Plant Mol. Biol. 14: 94-97; Tsai C J, Popko J L, Mielke M 
R, Flu W J, Podila G K, Chiang V L. 1998. Suppression of 
O-methyltransferase gene by homologous sense transgene in 
quaking aspen causes red-brown wood phenotypes. Plant 
Physiol. 117: 101-12.
Microprojectile-mediated transformation also is a well 
known method of introducing an exogenous nucleic acid 
molecule into a variety of seed plant species. This method, 
first described by Klein et al., Nature 327:70-73 (1987), 
which is incorporated herein by reference, relies on micro­
projectiles such as gold or tungsten that are coated with the 
desired nucleic acid molecule by precipitation with calcium 
chloride, spermidine or PEG. The microprojectile particles 
are accelerated at high speed into seed plant tissue using a 
device such as the Biolistic™ PD-1000 (Biorad, Flercules, 
Calif.).
Microprojectile-mediated delivery or “particle bombard­
ment” is especially useful to transform seed plants that are 
difiScult to transform or regenerate using other methods. 
Microprojectile-mediated transformation has been used, for 
example, to generate a variety of transgenic seed plant 
species, including cotton, tobacco, com, hybrid poplar and 
papaya (see, for example, Glick and Thompson, supra, 
1993). The transformation of important cereal crops such as 
wheat, oat, barley, sorghum and rice also has been achieved 
using microprojectile-mediated delivery (Duan et al., Nature 
Biotech. 14:494-498 (1996); Shimamoto, Curr. Opin. Bio­
tech. 5:158-162 (1994), each of which is incorporated 
herein by reference). A rapid transformation regeneration 
system for the production of transgenic plants, such as 
transgenic wheat, in two to three months also can be useful 
in producing a transgenic seed plant of the invention (Euro­
pean Patent No. EP 0 709 462 A2, Application number 
95870117.9, filed Oct. 25, 1995, which is incorporated 
herein by reference). In addition to the methods for plant 
transformation and regeneration described above for making 
transgenic plants, other well-known methods can be 
employed.
Methods of transforming forest trees including both 
angiosperms and gymnosperms also are well known in the 
art. Transgenic angiosperms such as members of the genus
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Populus, which includes aspens and poplars, have been 
generated using Agrobacterium-mediated transformation, 
for example. In addition, transgenic Populus and sweetgum, 
are of interest for biomass production and for fuel produc­
tion. Transgenic gymnosperms, including conifers such as 
white spruce and larch, also have been obtained, for 
example, using microprojectile bombardment (Wang et ah, 
supra, 1995). The skilled artisan will recognize that Agro­
bacterium-mediated transformation such as Boerjan et ah, 
1997; Kamosky et al., 2000; Kim, J. H. 1998; Tsai et al, 
1994 and 1998; can be a very suitable method of introducing 
a nucleic acid molecule encoding a floral reproductive gene 
product into a seed plant according to the methods of the 
invention.
The term “converting axillary meristem to floral mer- 
istem,” as used herein, means promoting the formation of 
flower progenitor tissue where axillary progenitor tissue 
otherwise would be formed in the angiosperm and gyrnno- 
sperm. As a result of the conversion of axillary meristem to 
floral meristem, flowers form in an angiosperm or gyrnno- 
sperm where axillary meristems normally would form. The 
conversion of axillary meristem to floral meristem can be 
identified using well known methods, such as scanning 
electron microscopy, light microscopy or visual inspection 
(see, for example, Mandel and Yanofsky, Plant Cell 
7:1763-1771 (1995), which is incorporated herein by ref­
erence).
A “promoter” is a polynucleotide containing element such 
as a TATA box, which is capable of binding RNA poly­
merase in a cell and initiating transcription of a downstream 
(3' direction) coding sequence. For purposes of defining the 
present invention, the promoter sequence is bounded at its 3' 
terminus by the transcription initiation site and extends 
upstream (5' direction) to include the minimum number of 
bases or elements necessary to initiate transcription at levels 
detectable above background. Within the promoter sequence 
will be found a transcription initiation site (conveniently 
defined, for example, by mapping with nuclease SI), as well 
as protein binding domains (consensus sequences) respon­
sible for the binding of RNA polymerase. Examples of 
promoters that can be used in the present invention include 
constitutive, tissue and temporal specific promoters.
A variety of plant gene promoters that are regulated in 
response to environmental, hormonal, chemical, and/or 
developmental signals, also can be used for expression of the 
floral reproductive genes in plant cells, including promoters 
regulated by: (a) heat (Ainley et al. (1993). Regulatable 
endogenous production of cytokinins up to “toxic” levels in 
transgenic plants and plant tissues. Plant Mol. Biol. 
22:13-23.); (b) light (e.g., the pea rbcS-3Apromoter (Kuhle- 
meier et al. (1989). Plant Cell 1:471.) and the maize rbcS 
promoter (SchafiSer and Sheen (1991). Plant Cell 3:997.), (c) 
hormones, such as abscisic acid (Marcotte et al. (1989). 
Plant Cell 1:969.), (d) wounding (Siebertz et al. (1989.), 
Plant Cell 1:961.), and (e) chemicals such as methyl jasmi- 
nate or salicylic acid (Gatz (1997). Chemical control of gene 
expression. Ann. Rev. Plant Physiol. Plant Mol. Biol. 
48:89-108.) can also be used to regulate gene expression.
Alternatively, tissue specific promoters (i.e., root, leaf, 
flower, and seed for example) can be fused to the coding 
sequence to obtain particular expression in respective 
organs. (Denis et al. (1993). Expression of engineered 
nuclear male sterility in Brassica napus. Plant Physiol. 101: 
1295-1304.) In addition, the timing of the protein expres­
sion can be controlled by using promoters such as those 
acting at senescencing (See, Gan and Amasino (1995), 
inhibition of leaf senescence by autoregulated production of
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cytokinin. Science 270:1986-1988.) or during late seed 
development (See, Odell et al. (1994). Seed specific gene 
activation mediated by the Cre/lox site-specific recombina­
tion system. Plant Physiol. 106:447-458). Therefore, there 
are a variety of different types of promoters that may be used 
in this invention.
The term “tissue-specific promoter” refers to a promoter 
which directs the expression of a gene into a specific tissue 
such as reproductive tissues.
The term “temporal-specific promoter” refers to a pro­
moter which temporally directs the expression of a gene so 
that the gene expression in the plant can be regulated based 
on time i.e., seasonally.
Furthermore, an appropriate regulatory element such as a 
promoter may be selected depending on the desired pattern 
or level of expression of a nucleic acid molecule linked 
thereto. For example, a constitutive promoter, which is 
active in all tissues, would be appropriate if expression of a 
gene product in all plant tissues is desired. In addition, a 
developmentally regulated or tissue-specific or temporal- 
specific regulatory element can be useful to direct floral 
reproductive gene expression to specific tissues, for 
example. As discussed above, inducible expression also can 
be particularly useful to manipulate the timing of gene 
expression such that, for example, a population of transgenic 
plants, such as seed plants of the invention that contain an 
expression vector comprising a floral reproductive gene 
linked to an inducible regulatory element, can undergo early 
reproductive development at essentially the same time. 
Selecting the time of reproductive development can be 
useful, for example, in manipulating the time of crop har­
vest.
The term “operably linked,” as used in reference to a 
regulatory element, such as a promoter, and a nucleic acid 
molecule encoding a floral reproductive gene product, 
means that the regulatory element confers regulated expres­
sion upon the operably linked nucleic acid molecule encod­
ing the floral reproductive gene product. Thus, the term 
“operably linked”, as used herein, refers to a promoter, such 
as for example SEQ ID NO:3 or a functionally equivalent 
sequence thereof, linked to a nucleic acid molecule encoding 
a floral reproductive gene product, such as SEQ ID NO: 1 or 
a functionally equivalent sequence thereof, such that the 
promoter may increase or decrease expression of the floral 
reproductive gene product. It is recognized that two nucleic 
acid molecules that are operably linked contain, at a mini­
mum, all elements essential for transcription, including, for 
example, a TATA box. One skilled in the art knows, for 
example, that a regulatory element that lacks minimal pro­
moter elements can be combined with a nucleic acid mol­
ecule having minimal promoter elements and a nucleic acid 
molecule encoding a floral reproductive gene product such 
that expression of the floral reproductive gene product can 
be increased in the presence of the appropriate inducing 
agent.
The term “inducing agent,” as used herein, means a 
substance or condition that effects increased expression of a 
nucleic acid molecule operably linked to a particular induc­
ible regulatory element as compared to the level of expres­
sion of the nucleic acid molecule in the absence of the 
inducing agent. An inducing agent can be, for example, a 
naturally occurring or synthetic chemical or biological mol­
ecule such as a simple or complex organic molecule, a 
peptide, a protein or an oligonucleotide that increases 
expression of a nucleic acid molecule operably linked to a 
particular inducible regulatory element. Examples of such 
inducing agents include compounds such as copper sulfate,
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tetracycline or an ecdysone. An inducing agent also can be 
a condition such as heat manifest by a certain temperature or 
light of a certain wavelength.
One skilled in the art can readily determine the optimum 
concentration of an inducing agent needed to produce 
increased expression of a nucleic acid molecule operably 
linked to an inducible promoter in a transgenic seed plant of 
the invention. For conveniently determining the optimum 
concentration of inducing agent from a range of useful 
concentrations, one skilled in the art can operably link the 
particular inducible promoter to a nucleic acid molecule 
encoding a reporter gene product such as beta-glucou- 
ronidase (GUS) and assay for reporter gene product activity 
in the presence of various concentrations of inducing agent 
(see, for example, Jefferson et al., EMBO J. 6:3901-3907 
(1987), which is incorporated herein by reference).
The nucleic acid molecules encoding floral reproductive 
gene products provided herein also can be useful in gener­
ating sterile transgenic seed plants and in methods of pro­
ducing reproductive sterility in seed plants. The methods of 
the invention involve producing a reproductively sterile 
transgenic plant, such as a seed plant having a variety of uses 
including safely growing transgenic trees in close contact 
with interfertile wild trees, increasing wood production and 
reducing allergenic pollen production. A method for pro­
ducing reproductive sterility in seed plants, which is useful 
for transgene containment, can allow, for example, the 
introduction of transgenic trees into the environment. Of 
particular concern to the introduction of transgenic trees into 
the environment is the possibility of enhanced “weediness” 
or the movement of transgenes by cross-fertilization into 
gene pools of wild relatives. Most commercially grown 
forest trees, for example, are grown in close proximity to 
interfertile wild populations, and gene flow within and 
among tree populations usually is extensive, making the 
probability of transgene escape from plantations of fertile 
transgenic trees high. Regulatory agencies have based 
approval of transgenic tree planting on sexual isolation of 
the transgenic species; for example, approval of two field 
tests for transgenic poplars by the Animal and Plant Fiealth 
Inspection Service (APFilS) was contingent on the trees not 
being allowed to flower (see, for example, Strauss et al., 
Molec. Breed 1:5-26 (1995), which is incorporated herein 
by reference). Thus, transgene containment through, for 
example, the use of sterile transgenic trees is central to the 
usefulness of improved transgenic varieties.
Methods of producing reproductively sterile seed plants 
also can be useful for increasing wood production, since 
substantial energy and nutrients are committed to reproduc­
tive development in trees. For example, in trees such as 
radiata pine, white spruce, balsam fir and Douglas fir, 
reduced growth, as measured by height or stem volume, is 
correlated with the early production of cones (Strauss et al., 
supra, 1995). Thus, the methods of the invention, which 
prevent flowering or cone development, for example, by 
producing reproductive sterility, are useful for growing 
substantially larger trees, thus increasing wood production.
A method for producing reproductively sterile plants, 
such as seed plants, also can be useful for alleviating 
allergies caused by tree pollen. For example, in Japan many 
people suffer from allergies caused by the most commonly 
planted forest tree, the conifer sugi (Strauss et al., supra, 
1995). The methods of the invention, therefore, can be 
suitable for preventing pollen formation in seed plants such 
as the conifer sugi.
Cosuppression, which relies on expression of a nucleic 
acid molecule in the sense orientation, is a well known
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methodology that produces coordinate silencing of the intro­
duced nucleic acid molecule and the homologous endog­
enous gene (see, for example, Flavell, Proc. Natl. Acad. Sci., 
USA 91:3490-3496 (1994), which is incorporated herein by 
reference). Although the mechanism of cosuppression is 
unknown, cosuppression is induced most strongly by a large 
number of transgene copies or by overexpression of trans­
gene RNA; cosuppression also can be enhanced by modi­
fication of the transgene such that it fails to be translated. 
Cosuppression has been used successfully to produce sterile 
plants; for example, a sense nucleic acid molecule contain­
ing a full-length fbpl coding sequence under the control of 
the strong CaMV 35S promoter has been introduced into 
petunia. Two of twenty-one transformants exhibited an 
abnormal phenotype and contained multiple copies of the 
fbpl transgene. Furthermore, fbpl expression was undetect­
able in these sterile transgenic plants, indicating that expres­
sion of endogenous fbpl was suppressed (Angenent et al., 
The Plant Journal 4:101-112 (1993), which is incorporated 
herein by reference).
Antisense nucleic acid molecules, which can act by reduc­
ing mRNA translation or by increasing mRNA degradation, 
for example, also can suppress gene expression of diverse 
genes and seed plant species (see, for example, Kooter et al., 
Mol, Current Opin. Biol. 4:166-171 (1993), which is incor­
porated herein by reference; see also Strauss et al., supra, 
1995). Antisense nucleic acid molecules previously have 
been used to successfully suppress the expression of a 
homologous endogenous gene, thereby generating sterile 
plants. For example, an antisense chalcone synthase gene 
under control of the CaMV 35S promoter with an anther- 
specific enhancer sequence effectively suppressed endog­
enous chalcone synthase expression levels, resulting in male 
sterility in transgenic petunia plants (Van der Meer et al., The 
Plant Cell Vol 4:253-262 (1992), which is incorporated 
herein by reference). Similarly, the full-length tomato TM5 
MADS box gene, when placed in antisense orientation under 
control of the CaMV 35S promoter, was used to produce 
sterile transgenic tomato plants (Pnuell et al., The Plant Cell, 
Vol. 6, 175-186 (1994), which is incorporated herein by 
reference).
Plant reproductive sterility can also occur through other 
traditional molecular methods such as by fusing the pro­
moter to a cytotoxic gene such as an RNAse gene or through 
using constructs with inverted repeat sequences. Gene sup­
pression can also occur by methods such as RNA interfer­
ence (RNAi), inverted repeat constructs and post-transcrip- 
tional gene silencing (PTGS) processes in which double- 
stranded (ds) RNA induces the degradation of homologous 
RNA sequences. In plants, transcriptional gene silencing 
resulting from sequence homology in promoter regions has 
also been observed and correlated with increased promoter 
methylation. (Kooter et al., Trends Plant Sci., 4, 340-346 
(1999).
Plant gene suppression may also result in delayed repro­
ductive growth. The delayed reproductive may increase the 
length of the vegetative growth stage and cause the plants to 
grow faster, since the energy used for development of 
flowers and seeds can be saved for vegetative growth. Thus, 
delaying or eliminating reproductive growth results in a 
higher yield of vegetable species such as spinach, radish, 
cabbage, or tree species. In addition, such plants will be 
more desirable for as garden and street species, since their 
production of pollen alleigens can be reduced or eliminated
The methods of the invention for producing reproductive 
sterility rely upon introducing into the genome of a seed 
plant one or more sense or antisense nucleic acid molecules
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encoding a floral reproductive gene product, or a function­
ally equivalent fragment thereof, such that expression of 
PtM3, homolog or ortholog gene products, including expres­
sion of endogenous PtM3 or homolog gene products, is 
suppressed in the transgenic seed plant. The skilled artisan 
will recognize that effective suppression of endogenous 
PtM3 or homolog gene product expression depends upon the 
one or more introduced nucleic acid molecules having a high 
percentage of homology with the corresponding endogenous 
gene loci.
A highly homologous nucleic acid molecule is highly 
suitable in the methods of the invention. However, a sense 
or antisense nucleic acid molecule encoding only a fragment 
of PtM3 or its homolog coding sequence, can be useful in 
performing the methods of the invention and achieving plant 
suppression. For example, leaf-specific inhibition of GUS 
gene expression in transgenic tobacco plants using an anti- 
sense RNA with a 41-base homology spanning the transla­
tion start codon of the gene has been shown. (Cannon et ah, 
Plant Mol. Bio., 15:39-47 (1990).
As used herein in reference to a nucleic acid molecule 
encoding a floral reproductive gene product, the terms 
“sense” and “antisense” have their commonly understood 
meanings.
As used herein in reference to a nucleic acid molecule 
encoding a floral reproductive gene product, the term “frag­
ment” means a portion of the nucleic acid sequence con­
taining at least about 50 base pairs to the full-length of the 
nucleic acid molecule encoding the floral reproductive gene 
product. In contrast to an active fragment or a functionally 
equivalent fragment, as defined herein, a fragment of a 
nucleic acid molecule encoding a floral reproductive gene 
product need not encode a functional portion of a gene 
product. A fragment may also be a portion of the nucleic acid 
that is less than full-length and comprises at least a minimum 
length capable of hybridizing specifically with an PtM3 
nucleic acid according to the present invention (or a 
sequence complementary thereto) under stringent conditions 
as defined below. The length of such a fragment is suitably 
15 nucleotides or more, although a shorter nucleic acid can 
be employed as a probe or primer if it is shown to specifi­
cally hybridize under stringent conditions with a target 
nucleic acid by methods well known in the art.
In the methods of the invention for producing reproduc­
tive sterility, the sense or antisense nucleic acid molecule is 
expressed under control of a strong promoter that is 
expressed, at least in part, in floral meristem. The constitu­
tive cauliflower mosaic virus 35S promoter (Odell et ah, 
supra, 1985), for example, or other strong promoters as 
disclosed herein, can be useful in the methods of the 
invention. In addition, an RNA polymerase III promoter can 
be useful in methods of producing reproductive sterility 
using an antisense nucleic acid molecule (see, for example, 
Bourque and Folk, Plant Mol. Biol. 19:641-647 (1992), 
which is incorporated herein by reference).
As used herein, the term “heterologous regulatory ele­
ment” means a regulatory element or a promoter derived 
from a different gene than the gene encoding the floral 
reproductive gene product to which it is operably linked. A 
vector containing a floral reproductive gene, however, con­
tains a nucleic acid molecule encoding a floral reproductive 
gene product operably linked to a homolgous regulatory 
element. Such a vector does not contain a nucleic acid 
molecule encoding a floral reproductive gene product oper­
ably linked to a heterologous regulatory element and, thus, 
is not an expression vector of the invention.
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A useful plant gene construct or an expression vector can 
contain a constitutive regulatory element for expression of 
an exogenous nucleic acid molecule in all or most tissues of 
a plant, such as a seed plant. The use of a constitutive 
regulatory element can be particularly convenient because 
expression from the element is relatively independent of 
developmental^ regulated or tissue-specific factors. For 
example, the cauliflower mosaic virus 35S promoter (CaMV 
35S) is a well-characterized constitutive regulatory element 
that produces a high level of expression in all plant tissues 
(Odell et al., Nature 313:810-812 (1985), which is incor­
porated herein by reference). Furthermore, the CaMV 35S 
promoter can be particularly useful due to its activity in 
numerous different seed plant species (Benfey and Chua, 
Science 250:959-966 (1990), which is incorporated herein 
by reference; Odell et al., supra, 1985). Other constitutive 
regulatory elements useful for expression in a seed plant 
include, for example, the cauliflower mosaic virus 19S 
promoter; the Figwort mosaic virus promoter (Singer et al., 
Plant Mol. Biol. 14:433 (1990), which is incorporated herein 
by reference); and the nopaline synthase (nos) gene pro­
moter (An, Plant Physiol. 81:86 (1986), which is incorpo­
rated herein by reference).
In addition, an expression vector of the present invention 
can contain a regulated gene regulatory element such as a 
promoter or enhancer element. A particularly useful regu­
lated promoter is a tissue-specific or a temporal-specific 
promoter such as the PtM3 promoter which is both a 
tissue-specific and temporal-specific promoter. Another 
example of a regulated promoter is a shoot meristem- 
specific CDC2 promoter (Hemerly et al., Plant Cell. 
5:1711-1723 (1993), which is incorporated herein by refer­
ence).
As used herein in reference to a particular nucleic acid 
molecule or polynucleotide or gene product (i.e., polypep­
tide), the term “substantially purified” means that the par­
ticular nucleic acid molecule or gene product is in a form 
that is relatively free from contaminating lipids, unrelated 
gene products, unrelated nucleic acids or other cellular 
material normally associated with the particular nucleic acid 
molecule or gene product in a cell.
An “active fragment” or a “functionally equivalent frag­
ment” refers to a portion of a gene or a gene product that 
contains the essential sequences, such as the active site 
motif, which provides the sequence fragment with the ability 
to perform essentially the same function as the full-length 
gene or the gene product. An active fragment incorporated 
into the genome of a plant can be identified by phenotypic 
analysis of the plant which ectopically expresses the active 
fragment producing early flowering, etc. For analysis of a 
large number of active fragments of a PtM3 or its homolog, 
nucleic acid molecules encoding the active fragments can be 
assayed in pools, and active pools subsequently subdivided 
to identify the active nucleic acid molecule.
The term “functional portion” or “functional fragment” or 
“functional equivalent” of an enzyme is that portion, frag­
ment, or equivalent which contains the active site for bind­
ing one or more reactants or is capable of improving or 
regulating the rate of reaction. The active site may be made 
up of separate portions present on one or more polypeptide 
chains and will generally exhibit high substrate specificity.
As used herein, the term “variant” covers any sequence 
which exhibits at least about 75%, more suitably at least 
about 80% and, more suitably yet, at least about 90% 
identity to a sequence of the present invention. Sequence 
variants include not only genetically engineered sequence 
variants, but also naturally occurring variants that arise e.g.,
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within Populus populations, including allelic variants and 
polymorphisms, as well as variants that occur in different 
genotypes and plant species. Most suitably, a “variant” is 
any sequence which has at least about a 99% probability of 
being the same as the inventive sequence. Such probability 
for DNA sequences is measured by the computer algorithm 
FASTA (version 2.0u4, February 1996; Pearson W. R. et ah, 
Proc. Natl. Acad. Sci., 85:2444-2448, 1988), the probability 
for translated DNA sequences is measured by the computer 
algorithm TBLASTX and that for protein sequences is 
measured by the computer algorithm BLASTP (Altschul, S. 
F. et al. J. Mol. Biol., 215:403-410, 1990). The term 
“variants” thus encompasses sequences wherein the prob­
ability of finding a match by chance (smallest sum prob­
ability) in a database, is less than about 1% as measured by 
any of the above tests.
The term a “function-conservative variant” refers to a 
polypeptide (or a polynucleotide encoding the polypeptide) 
having a given amino acid residue that has been changed 
without altering the overall conformation and function of the 
polypeptide, including, but not limited to, replacement of an 
amino acid with one having similar physico-chemical prop­
erties (such as, for example, acidic, basic, hydrophobic, and 
the like). Amino acids with have similar physico-chemical 
properties are well known in the art. For example, arginine, 
histidine and lysine are hydrophilic-basic amino acids and 
may be interchangeable. Similarly, isoleucine, a hydropho­
bic amino acid, may be replaced with leucine, methionine or 
valine.
As used herein, the term “functionally equivalent variant 
of PtM3 or its homolog” encompasses an active segment of 
PtM3 or its homolog, which is a polypeptide portion of a 
PtM3 or its homolog that, when ectopically expressed, alters 
normal reproductive plant or tree development such that 
altered plant or tree properties are produced. An active 
fragment can be, for example, an amino terminal, internal or 
carboxy terminal fragment of Aspen PtM3 (SEQ ID NO:4) 
that, when ectopically expressed in a plant, alters normal 
reproductive development such that plants with altered 
reproductive capacity are produced. An active fragment of a 
PtM3 gene product can include, for example, the MADS 
domain and can have the ability to bind DNA specifically. 
The skilled artisan will recognize that a nucleic acid mol­
ecule encoding an active segment of PtM3 gene product can 
be used to generate a plant of the invention characterized by 
producing early flowering, etc. and in the related methods 
and kits of the invention described further below.
The term “oligonucleotide” refers to a nucleic acid, gen­
erally of at least 10, suitably at least 15, and more suitably 
at least 20 nucleotides, that is hybridizable to a genomic 
DNA molecule, a cDNA molecule, or an mRNA molecule 
encoding a gene, mRNA, cDNA, or other nucleic acid of 
interest. Oligonucleotides can be labeled, e.g., with 32P- 
nucleotides or nucleotides to which a label, such as biotin, 
has been covalently conjugated. In one embodiment, a 
labeled oligonucleotide can be used as a probe to detect the 
presence of a nucleic acid. In another embodiment, oligo­
nucleotides (one or both of which may be labeled) can be 
used as polymerase chain reaction (PCR) primers, either for 
cloning full length or a fragment of PtM3, or to detect the 
presence of nucleic acids encoding PtM3. In a further 
embodiment, an oligonucleotide of the present invention can 
form a triple helix with a PtM3 DNA molecule. In still 
another embodiment, a library of oligonucleotides arranged 
on a solid support, such as a silicon wafer or chip, can be 
used to detect various polymorphisms of interest. Generally, 
oligonucleotides are prepared synthetically, suitably on a
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nucleic acid synthesizer. Accordingly, oligonucleotides can 
be prepared with non-naturally occurring phosphoester ana­
log bonds, such as thioester bonds, etc.
The term “non-coding region” refers to that portion of the 
gene that does not directly encode a polypeptide. The 
boundaries of the non-coding region are located before the 
start codon and after the stop codon. The non-coding region 
includes the untranslated regions of the genomic DNA.
Also, as used herein, the term “gene” refers to a nucleic 
acid fragment that expresses a specific protein including the 
regulatory sequences preceding (5' noncoding) and follow­
ing (3' noncoding) the coding region. “Native” gene refers to 
the gene as found in nature with its own regulatory 
sequences.
The term “endogenous gene” refers to the native gene 
normally found in its natural location in the genome.
“Exogenous” refers to biological material, such as a 
polynucleotide or protein, that has been isolated from a cell 
and is then introduced into the same or a different cell. For 
example, a polynucleotide encoding a PtM3 gene of the 
invention can be cloned from xylem cells of a particular 
species of tree, inserted into a plasmid and reintroduced into 
xylem cells of the same or different species.
The term “transgene” refers to a homologous or heter­
ologous gene that is introduced by gene transfer methods 
disclosed herein into the cell, tissue or organ of a host 
organism. The term “transgenic” or “transformed” when 
referring to a cell or organism, also includes (1) progeny of 
the cell or organism and (2) plants produced from a breeding 
program employing such a “transgenic” plant as a parent in 
a cross and exhibiting an altered phenotype resulting from 
the presence of the recombinant PtM3 gene construct.
The term “PtM3 polypeptide” refers to a protein encoded 
by an PtM3 gene, including alleles and homologs of PtM3, 
functionally equivalent fragments, or by a variant of the 
PtM3 gene, having PtM3 biological activity. An PtM3 
polypeptide can be isolated from a natural source, produced 
by the expression of a recombinant PtM3 nucleic acid, or be 
chemically synthesized. Techniques for chemical synthesis 
of polypeptides are described, for example, in Merrifield, J. 
Amer. Chem. Soc. 85:2149-2156, 1963.
The polypeptides of the present invention can be purified 
by any of the means known in the art. Various methods of 
protein purification are described, e.g., in Guide to Protein 
Purification, ed. Deutscher, Meth. Enzymol. 185, Academic 
Press, San Diego, 1990; and Scopes, Protein Purification: 
Principles and Practice, Springer Verlag, New York, 1982.
Encompassed by the claimed PtM3 polypeptides are 
variant polypeptides in which there have been substitutions, 
deletions, insertions or other modifications of the native 
PtM3 polypeptide. The variants substantially retain struc­
tural and/or biological characteristics and are suitably silent 
or conservative substitutions of one or a small number of 
contiguous amino acid residues.
The native PtM3 polypeptide sequence can be modified 
by conventional methods, e.g., by acetylation, carboxyla- 
tion, phosphorylation, glycosylation, ubiquitination, and 
labeling, whether accomplished by in vivo or in vitro 
enzymatic treatment of an PtM3 polypeptide or by the 
synthesis of an PtM3 polypeptide using modified amino 
acids.
There are a variety of conventional methods and reagents 
for labeling polypeptides and fragments thereof. Typical 
labels include radioactive isotopes, ligands or ligand recep­
tors, fluorophores, chemiluminescent agents, and enzymes. 
Methods for labeling and guidance in the choice of labels 
appropriate for various purposes are discussed, e.g., in
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Molecular Cloning: A Laboratory Manual, 2nd ed., vol. 1-3, 
ed. Sambrook et al., Cold Spring Harbor Laboratory Press: 
Cold Spring Harbor, N.Y., 1989; and Current Protocols in 
Molecular Biology, ed. Ausubel et al., Greene Publishing 
and Wiley-Interscience: New York, 1987 (with periodic 
updates).
The present invention also encompasses fragments of 
PtM3 polypeptides that lack at least one residue of a native 
full-length PtM3 polypeptide yet retain at least one of the 
biological activities characteristic of Aspen PtM3. For 
example, such a fragment can cause early flowering when 
expressed as a transgene in a host plant or possession of a 
characteristic immunological determinant. As an additional 
example, an immunologically active fragment (i.e., anti­
genic determinants or epitopes) of an PtM3 polypeptide is 
capable of raising PtM3-specific antibodies in a target 
immune system (e.g., murine or rabbit) or of competing with 
PtM3 polypeptide for binding to PtM3-specific antibodies, 
and is thus useful in immunoassays for the presence of PtM3 
polypeptides in a biological sample. Such immunologically 
active fragments typically have a minimum size of 7 to 17 
amino acids.
The present invention also provides fusion polypeptides 
including, for example, heterologous fusion polypeptides, 
i.e., an PtM3 polypeptide sequence or fragment thereof and 
a heterologous polypeptide sequence, e.g., a sequence from 
a different polypeptide. Such heterologous fusion polypep­
tides, thus, exhibit biological properties (such as ligand­
binding, catalysis, secretion signals, antigenic determinants, 
etc.) derived from each of the fused sequences. Fusion 
partners include, for example, immunoglobulins, beta galac- 
tosidase, trpE, protein A, beta lactamase, alpha amylase, 
alcohol dehydrogenase, yeast alpha mating factor, and vari­
ous signal and leader sequences which, e.g., can direct the 
secretion of the polypeptide. Fusion polypeptides are typi­
cally made by the expression of recombinant nucleic acids 
or by chemical synthesis.
The term “coding sequence” refers to that portion of the 
gene that contains the information for encoding a polypep­
tide. The boundaries of the coding sequence are determined 
by a start codon at the 5' (amino) terminus and a translation 
stop codon at the 3' (carboxyl) terminus. A coding sequence 
can include, but is not limited to, prokaryotic sequences, 
cDNA from eukaryotic mRNA, genomic DNA sequences 
from eukaryotic (e.g., mammalian) DNA, and even synthetic 
DNA sequences
The term “encoding” and “coding” refer to the process by 
which a gene, through the mechanisms of transcription and 
translation, provides the information to a cell from which a 
series of amino acids can be assembled into a specific amino 
acid sequences to produce an active enzyme. It is understood 
that the process of encoding a specific amino acid sequence 
includes DNA sequences that may involve base changes that 
do not cause a change in the encoded amino acid, or which 
involve base changes which may alter one or more amino 
acids, but do not affect the functional properties of the 
protein encoded by the DNA sequence. It is therefore 
understood that the present invention encompasses more 
than the specific exemplary sequences. Modifications to the 
sequences, such as deletions, insertions or substitutions in 
the sequence which produce silent changes that do not 
substantially affect the functional properties of the resulting 
protein molecule, are also contemplated. For example, alter­
ations in the gene sequence which reflect the degeneracy of 
the genetic code, or which result in the production of a 
chemically equivalent amino acid at a given site, are con­
templated. Thus, a codon for the amino acid alanine, a
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hydrophobic amino acid, may be substituted by a codon 
encoding another less hydrophobic residue, such as glycine, 
or a more hydrophobic residue, such as valine, leucine or 
isoleucine. Similarly, changes which result in substitution of 
one negatively charged residue for another, such as aspartic 
acid for glutamic acid, or one positively charged residue for 
another, such as lysine for aiginine, can also be expected to 
produce a biologically equivalent product. Nucleotide 
changes which result in alteration of the N-terminal and 
C-terminal portions of the protein molecule would also not 
be expected to alter the activity of the protein. In some cases, 
it may, in fact, be desirable to make mutants of the sequence 
to study the effect of retention of biological activity of the 
protein. Each of these proposed modifications is well within 
the routine skill in the art, as is the determination of retention 
of biological activity in the encoded products. Moreover, the 
skilled artisan recognizes that sequences encompassed by 
the present invention are also defined by their ability to 
hybridize, under stringent condition, with the sequences 
exemplified herein.
The term “expression” is meant to refer to the production 
of a polypeptide encoded by a gene. “Overexpression” refers 
to the production of a polypeptide in transgenic organisms 
that exceed levels of production in normal or non-trans- 
formed organisms.
The term “% identity” refers to the percentage of the 
nucleotides/amino acids of one polynucleotide/polypeptide 
that are identical to the nucleotides/amino acids of another 
sequence of polynucleotide/polypeptide as identified by a 
program such as GAP from Genetics Computer Group 
Wisconsin (GCG) package (version 9.0) (Madison, Wis.). 
GAP uses the algorithm of Needleman and Wunsch (J. Mol. 
Biol. 48: 443-453, 1970) to find the alignment of two 
complete sequences that maximizes the number of matches 
and minimizes the number of gaps. When parameters 
required to run the above algorithm are not specified, the 
default values offered by the program are contemplated.
The “% similarity” or “% homology” between two 
polypeptide sequences is a function of the number of similar 
positions shared by two sequences on the basis of the scoring 
matrix used divided by the number of positions compared 
and then multiplied by 100. This comparison is made when 
two sequences are aligned (by introducing gaps if needed) to 
determine maximum homology. PowerBlast program, 
implemented by the National Center for Biotechnology 
Information, can be used to compute optimal, gapped align­
ments. GAP program from Genetics Computer Group Wis­
consin package (version 9.0) (Madison, Wis.) can also be 
used. GAP uses the algorithm of Needleman and Wunsch {J. 
Mol. Biol. 48: 443—453, 1970) to find the alignment of two 
complete sequences that maximizes the number of matches 
and minimizes the number of gaps. When parameters 
required to run the above algorithm are not specified, the 
default values offered by the program are contemplated. The 
following parameters are used by the GCG program GAP as 
default values (for polypeptides): gap creation penalty:12; 
gap extension penalty:4; scoring matrix:Blosum62.cpm (lo­
cal data file).
A first nucleic acid is “substantially similar” to a second 
nucleic acid if, when optimally aligned (with appropriate 
nucleotide insertions or deletions) with the other nucleic 
acid (or its complementary strand), there is nucleotide 
sequence identity in at least about 75%-90% of the nucle­
otide bases, and suitably greater than 90% of the nucleotide 
bases. (“Substantial sequence complementarity” requires a 
similar degree of sequence complementarity.) Sequence 
similarity can be determined by comparing the nucleotide
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sequences of two nucleic acids using sequence analysis 
software such as the Sequence Analysis Software Package of 
the Genetics Computer Group, University of Wisconsin 
Biotechnology Center, Madison, Wis.
Alternatively, two nucleic acids are substantially similar if 
they hybridize under stringent conditions, as defined below.
A “homolog” of the PtM3 gene is a native gene sequence 
isolated from a plant species other than Aspen that has at 
least one of the biologically activities of PtM3, e.g., affecting 
early flowering in transgenic plants, etc., as discussed above.
The term “ortholog” as used herein refers to orthologous 
genes, wherein the gene loci in different species are suffi­
ciently similar in their nucleotide sequences to suggest that 
they originated from a common ancestral gene. (See Pei- 
Show Juo, Concise Dictionary o f Biomedicine and Molecu­
lar Biology (CRC Press 2d ed. 2002)).
An “isolated polynucleotide” refers to a component that is 
removed from its original environment (for example, its 
natural environment if it is naturally occurring). An isolated 
nucleic acid or polypeptide may contains less than about 
50%, suitably less than about 75%, and most suitably less 
than about 90%, of the cellular components with which it 
was originally associated. A polynucleotide amplified using 
PCR so that it is sufficiently and easily distinguishable (on 
a gel, for example) from the rest of the cellular components 
is considered “isolated”. The polynucleotides and polypep­
tides of the present invention may be “substantially pure,” 
i.e., having the highest degree of purity that can be achieved 
using purification techniques known in the art.
A “polynucleotide” is intended to include double or single 
stranded genomic and cDNA, RNA, any synthetic and 
genetically manipulated polynucleotide, and both sense and 
anti-sense strands together or individually (although only 
sense or anti-sense stand may be represented herein). This 
includes single- and double-stranded molecules, i.e., DNA- 
DNA, DNA-RNA and RNA-RNA hybrids, as well as “pro­
tein nucleic acids” (PNA) formed by conjugating bases to an 
amino acid backbone. This also includes nucleic acids 
containing modified bases, for example thio-uracil, thio- 
guanine and fluoro-uracil. Polynucleotide also encompasses 
a nucleic acid, the structure of which is not identical to that 
of any naturally occurring nucleic acid or to that of any 
fragment of a naturally occurring genomic nucleic acid 
spanning more than three separate genes. The term, there­
fore, covers, for example, (a) a DNA which has the sequence 
of part of a naturally occurring genomic DNA molecules but 
is not flanked by both of the coding sequences that flank that 
part of the molecule in the genome of the organism in which 
it naturally occurs; (b) a nucleic acid incorporated into a 
vector or into the genomic DNA of a prokaryote or eukary­
ote in a manner such that the resulting molecule is not 
identical to any naturally occurring vector or genomic DNA; 
(c) a separate molecule such as a cDNA, a genomic frag­
ment, a fragment produced by PCR, or a restriction frag­
ment; and (d) a recombinant nucleotide sequence that is part 
of a hybrid gene, i.e., a gene encoding a fusion protein. 
Specifically excluded from this definition are nucleic acids 
present in mixtures of (i) DNA molecules, (ii) transfected 
cells, and (iii) cell clones, e.g., as these occur in a DNA 
library such as a cDNA or genomic DNA library.
The term “vector” is a recombinant nucleic acid construct, 
such as a plasmid, phage, genome, virus genome, cosmid, or 
artificial chromosome, to which a polynucleotide of the 
present invention may be attached. In a specific embodi­
ment, the vector may bring about the replication of the 
attached segment, e.g., in the case of a cloning vector.
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The term “expression cassette” or “gene construct” refers 
to a polynucleotide which contains both a promoter and a 
protein coding sequence such that expression of a given 
protein is achieved upon insertion of the expression cassette 
into a cell.
DNA constructs incorporating an PtM3 gene or fragment 
thereof according to the present invention suitably place the 
PtM3 protein coding sequence under the control of an 
operably linked promoter that is capable of expression in a 
plant cell. Various promoters suitable for expression of 
heterologous genes in plant cells are known in the art, 
including constitutive promoters, e.g. the cauliflower mosaic 
virus (CaMV) 35S promoter, which is expressed in many 
plant tissues, organ- or tissue-specific promoters, and tissue- 
specific or temporal-specific promoters that direct the 
expression of the desired gene into specific reproductive 
tissue and/or at specific times of the year, for example.
Natural or synthetic nucleic acids according to the present 
invention can be incorporated into recombinant nucleic-acid 
constructs, typically DNA constructs, capable of introduc­
tion into and replication in a host cell. Usually the DNA 
constructs will be suitable for replication in a unicellular 
host, such as E. coli or other commonly used bacteria, but 
can also be introduced into yeast, mammalian, plant or other 
eukaryotic cells.
Suitably, such a nucleic-acid construct is a vector com­
prising a replication system recognized by the host. For the 
practice of the present invention, well-known compositions 
and techniques for preparing and using vectors, host cells, 
introduction of vectors into host cells, etc. are employed, as 
discussed, inter alia, in Sambrook et al., 1989, or Ausubel et 
al, 1987.
Methods for chemical synthesis of nucleic acids are 
discussed, for example, in Beaucage and Carruthers, Tetra. 
Letts. 22:1859-1862, 1981, and Matteucci et al., J. Am. 
Chem. Soc. 103:3185, 1981. Chemical synthesis of nucleic 
acids can be performed, for example, on commercial auto­
mated oligonucleotide synthesizers.
As used herein, “amplified DNA” refers to the product of, 
nucleic-acid amplification of a taiget nucleic-acid sequence. 
Nucleic-acid amplification can be accomplished by any of 
the various nucleic-acid amplification methods known in the 
art, including the PCR. A variety of amplification methods 
are known in the art and are described, inter alia, in U.S. Pat. 
Nos. 4,683,195 and 4,683,202 and in PCR Protocols: A 
Guide to Methods and Applications, Innis et al. eds., Aca­
demic Press, San Diego, 1990.
The term “hybridization” conditions refers to the condi­
tions used herein for isolating a gene, for example, the 
conditions are relatively stringent such that non-specific 
hybridization is minimized. Appropriate hybridization con­
ditions can be determined empirically, or can be estimated 
based, for example, on the relative G+C content of the probe 
and the number of mismatches between the probe and taiget 
sequence, if known. Flybridization conditions can be 
adjusted as desired by varying, for example, the temperature 
of hybridizing or the salt concentration (Sambrook, supra, 
1989).
Flybridization requires that the two polynucleotides con­
tain substantially complementary sequences; depending on 
the stringency of hybridization, however, mismatches may 
be tolerated. Typically, hybridization of two sequences at 
high stringency (such as, for example, in an aqueous solu­
tion of 0.5xSSC at 65° C.) requires that the sequences 
exhibit some high degree of complementarity over their 
entire sequence. Conditions of intermediate stringency (such 
as, for example, an aqueous solution of 2xSSC at 65° C.) and
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low stringency (such as, for example, an aqueous solution of 
2xSSC at 55° C.), require correspondingly less overall 
complementarity between the hybridizing sequences. 
(lxSSC is 0.15 M NaCl, 0.015 M Na citrate.) As used 
herein, the above solutions and temperatures refer to the 
probe-washing stage of the hybridization procedure. The 
term “a polynucleotide that hybridizes under stringent (low, 
intermediate) conditions” is intended to encompass both 
single and double-stranded polynucleotides although only 
one strand will hybridize to the complementary strand of 
another polynucleotide. See also, Sambrook et al., 1989 at 
9.47-9.52, 9.56-9.58; Kanehisa, Nuc. Acids Res.
12:203-213, 1984; and Wetmur and Davidson, J. Mol. Biol. 
31:349-370, 1968.
The invention also provides a kit for over-expression and 
suppressed expression of floral reproductive genes in plants. 
The kit may include at least one of the PtM3 gene, the PtM3 
gene product, homologs, orthologs, functionally equivalent 
fragments, primers, promoters, fragments, antibodies, gene 
constructs, expression vectors, host cells, appropriate 
reagents to facilitate high efiSciency transformation of a seed 
plant and combinations thereof; wherein the over-expression 
may result in plants having at least one of accelerated or 
early flowering; increased fruit production; increased nut 
production; increased seed output; increased branching; 
increased flower production; increased fruit yield; increased 
flower yield a plant, and a combination thereof and the 
suppressed expression may result in at least one of complete 
sterility; partial sterility; reduced pollen production, 
decreased flowering, increased biomass and combinations 
thereof.
If desired, a kit of the invention also can contain a plant 
expression vector. As used herein, the term “plant expression 
vector” means a self-replicating nucleic acid molecule that 
provides a means to transfer an exogenous nucleic acid 
molecule into a seed plant host cell and to express the 
molecule therein. Plant expression vectors encompass vec­
tors suitable for Agrobacterium-mediated transformation, 
including binary and cointegrating vectors, as well as vec­
tors for physical transformation.
Plant expression vectors can be used for transient expres­
sion of the exogenous nucleic acid molecule, or can integrate 
and stably express the exogenous sequence. One skilled in 
the art understands that a plant expression vector can contain 
all the functions needed for transfer and expression of an 
exogenous nucleic acid molecule; alternatively, one or more 
functions can be supplied in trans as in a binary vector 
system for Agrobacterium-mediated transformation.
In addition to containing a nucleic acid molecule encod­
ing an PtM3 gene product operatively linked to a regulatory 
element, a plant expression vector of the invention can 
contain, if desired, additional elements. A binary vector for 
Agrobacterium-mediated transformation contains one or 
both T-DNA border repeats and can also contain, for 
example, one or more of the following: a broad host range 
replicon, an ori T for efiScient transfer from E. coli to 
Agrobacterium, a bacterial selectable marker such as ampi- 
cillin and a polylinker containing multiple cloning sites.
A plant expression vector for physical transformation can 
have, if desired, a plant selectable marker and can be based 
on a vector such as pBR322, pUC, pGEM and Ml 3, which 
are commercially available, for example, from Pharmacia 
(Piscataway, N.J.) or Promega (Madison, Wis.). In plant 
expression vectors for physical transformation of a seed 
plant, the T-DNA borders or the ori T region can optionally 
be included but provide no advantage.
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The definition of the terms “complement”, “reverse 
complement” and “reverse sequence”, as used herein, is best 
illustrated by the following example. For the sequence 5' 
AGGACC 3', the complement, reverse complement and 
reverse sequence are as follows:
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co m p le m en t 3 ' TCCTGG 5 '
r e v e r s e  c o m p lem en t 3 ' GGTCCT 5 '
r e v e r s e  s e q u e n c e 5 ' CCAGGA 3 '
Variants of the isolated sequences commercially impor­
tant species utilized by the lumber industry, are contem­
plated. These include the following gymnosperms, by way 
of example: loblolly pine Pinus taeda, slash pine Pinus 
elliotti, sand pine Pinus clausa, longleaf pine Pinus palus- 
trus, shortleaf pine Pinus echinata, ponderosa pine Pinus 
ponderosa, Jeffrey pine Pinus jeffrey, red pine Pinus resi- 
nosa, pitch pine Pinus rigida, jack pine Pinus banksiana, 
pond pine Pinus serotina, Eastern white pine Pinus strobus, 
Western white pine Pinus monticola, sugar pine Pinus 
lambertiana, Virginia pine Pinus virginiana, lodgepole pine 
Pinus contorta, Caribbean pine Pinus caribaea, P. pinaster, 
Calabrian pine P. brutia, Afghan pine P. eldarica, Coulter 
pine P. coulteri, European pine P. nigra and P. sylvestris; 
Douglas-fir Pseudotsuga menziesii; the hemlocks which 
include Western hemlock Tsuga heterophylla, Eastern hem­
lock Tsuga canadensis, Mountain hemlock Tsuga mertensi- 
ana; the spruces which include the Norway spruce Picea 
abies, red spruce Picea rubens, white spruce Picea glauca, 
black spruce Picea mariana, Sitka spruce Picea sitchensis, 
Englemann spruce Picea engelmanni, and blue spruce Picea 
pungens; redwood Sequoia sempervirens; the true firs 
include the Alpine fir Abies lasiocarpa, silver fir Abies 
amabilis, grand fir Abies grandis, nobel fir Abies procera, 
white fir Abies concolor, California red fir Abies magnifica, 
and balsam fir Abies balsamea, the cedars which include the 
Western red cedar Thuja plicata, incense cedar libocedrus 
decurrens, Northern white cedar Thuja occidentalis, Port 
Orford cedar Chamaecyparis lawsoniona, Atlantic white 
cedar Chamaecyparis thyoides, Alaska yellow-cedar 
Chamaecyparis nootkatensis, and Eastern red cedar Huni- 
perus virginiana; the larches which include Eastern larch 
Larix laricina, Western larch Larix occidentalis, European 
larch Larix decidua, Japanese larch Larix leptolepis, and 
Siberian larch Larix siberica; bold cypress Taxodium disti- 
chum and Giant sequoia Sequoia gigantea; and the follow­
ing angiosperms, by way of example: Eucalyptus alba, E. 
bancroftii, E. botyroides, E. bridgesiana, E. calophylla, E. 
camaldulensis, E. citriodora, E. cladocalyx, E. coccifera, E. 
curtisii, E. dalrympleana, E. deglupta, E. delagatensis, E. 
diversicolor, E. dunnii, E. ficifolia, E. globulus, E. gompho- 
cephala, E. gunnii, E. henryi, E. laevopinea, E. macarthurii, 
E. macrorhyncha, E. maculata, E. marginata, E. megacarpa, 
E. melliodora, E. nicholii, E. nitens, E. nova-angelica, E. 
obliqua, E. obtusiflora, E. oreades, E pauciflora, E. poly- 
bractea, E. regnans, E. resinifera, E. robusta, E. rudis, E. 
saligna, E. sideroxylon, E. stuartiana, E. tereticornis, E. 
torelliana, E. urnigera, E. urophylla, E. viminalis, E. viridis, 
E. wandoo and E. youmanni.
The availability of the PtM3 gene and its sequence makes 
it possible to obtain homologs or orthologs of the PtM3 gene 
in other organisms by conventional methods, through the use 
of nucleic acid and antibody probes and DNA primers based 
on the PtM3 sequence, as described in greater detail below. 
For example, these probes and primers are also useful in
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research on the patterns of expression and structure-function 
relationships for Aspen PtM3 and its homologs or orthologs, 
and for determining the interaction of these genes with other 
plant genes involved in floral development.
Nucleic acid probes and primers can be prepared based on 
nucleic acids according to the present invention, e.g., the 
PtM3 gene of FIG. 1 (SEQ ID NO:l) or the PtM4 gene of 
FIG. 2 (SEQ ID NO:2). A “probe” comprises an isolated 
nucleic acid attached to a detectable label or reporter mol­
ecule well known in the art. Typical labels include radioac­
tive isotopes, ligands, chemiluminescent agents, and 
enzymes.
“Primers” are short nucleic acids, suitably DNA oligo­
nucleotides 15 nucleotides or more in length, which are 
annealed to a complementary target DNA strand by nucleic 
acid hybridization to form a hybrid between the primer and 
the taiget DNA strand, then extended along the target DNA 
strand by a polymerase, suitably a DNA polymerase. Primer 
pairs can be used for amplification of a nucleic acid 
sequence, e.g., by the polymerase chain reaction (PCR) or 
other nucleic-acid amplification methods well known in the 
art. PCR-primer pairs can be derived from the sequence of 
a nucleic acid according to the present invention, for 
example, by using computer programs intended for that 
purpose such as Primer (Version 0.5, COPYRGT. 1991, 
Whitehead Institute for Biomedical Research, Cambridge, 
Mass.).
Methods for preparing and using probes and primers are 
described, for example, in Sambrook et ah, Molecular 
Cloning: A Laboratory Manual, 2nd ed., vol. 1-3, ed. 
Sambrook et al., Cold Spring Flarbor Laboratory Press, Cold 
Spring Flarbor, N.Y., 1989; Current Protocols in Molecular 
Biology, ed. Ausubel et al., Greene Publishing and Wiley- 
Interscience, New York, 1987 (with periodic updates); and 
Innis et al., PCR Protocols: A Guide to Methods and 
Applications, Academic Press: San Diego, 1990. Probes or 
primers can be free in solution or covalently or nonco- 
valently attached to a solid support by standard means.
“reproductive unit or structure” of a plant is any totipotent 
part or tissue of the plant from which one can obtain a 
progeny of the plant, including, for example, seeds, cuttings, 
buds, bulbs, somatic embryos, etc.
The term “female reproductive structure” as used herein 
means those portions of a plant which compose the carpel, 
or gynoecium (an old established term used with regard to 
the gynoecium is “pistil”). The carpel of a flower of a plant 
includes but is not limited to a stigma, style, ovary, and cells 
or tissues which comprise the stigma, style and ovary.
As used herein, the term “antibody” is used in its broadest 
sense to include naturally occurring and non-naturally 
occurring polyclonal and monoclonal antibodies, as well as 
a polypeptide fragment of an antibody that retains a specific 
binding activity of at least about 1x10s 1/M for a PtM3 gene 
product (SEQ ID NO:4) or a homolog thereof (SEQ ID 
NO: 5), such as PtM4 gene product. One skilled in the art 
would recognize that an antibody fragment such as a Fab, 
F(ab')2 or Fv fragment can retain specific binding activity for 
a PtM3 gene product or a homolog thereof, thus, is included 
within the definition of an antibody. A non-naturally occur­
ring antibody, or fragment thereof, such as a chimeric 
antibody or humanized antibody also is included within the 
meaning of the term antibody. Such a non-naturally occur­
ring antibody can be constructed using solid phase peptide 
synthesis, produced recombinantly or obtained, for example, 
by screening a combinatorial library consisting of variable
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heavy chains and variable light chains as described by Fluse 
et al., Science 246:1275-1281 (1989), which is incorporated 
herein by reference.
An antibody “specific for” a polypeptide, or that “spe­
cifically binds” a polypeptide, binds with substantially 
higher afiSnity to that polypeptide than to an unrelated 
polypeptide. An antibody specific for a polypeptide also can 
have specificity for a related polypeptide. For example, an 
antibody specific for an Aspen PtM3 polypeptide or a 
homolog thereof, can specifically bind another plant PtM3 
polypeptide or a homolog, such as an angiosperm, specifi­
cally, such as Arabidopsis thaliana PtM3 polypeptide or a 
tobacco PtM3 polypeptide. An antibody specific for an 
antigenic determinant or a epitopic region which consists of 
virtually any detectable epitope varying in amino acid 
length, that may be employed as a screenable marker, can be 
selected from the extremely wide variety of antigemanti- 
body combinations known to those of skill in the art. The 
unique extracellular epitope, whether derived from PtM3 or 
any other protein or epitopic substance, can then be straight­
forwardly detected using antibody labeling in conjunction 
with chromogenic or fluorescent adjuncts.
The invention encompasses the production of an antibody 
to the PtM3 protein, homologs and orthologs and functional 
fragments thereof. Monoclonal or polyclonal antibodies may 
be produced to either the normal PtM3 protein or mutated 
forms of this protein. The determination that an antibody 
specifically detects the PtM3 protein is made by any one of 
a number of standard immunoassay methods; for instance, 
the Western blotting technique (Sambrook et al., 1989). To 
determine that a given antibody preparation (such as one 
produced in a mouse) specifically detects the PtM3 protein 
by Western blotting, total cellular protein is extracted from 
rice cells and electrophoresed on a sodium dodecyl sulfate- 
polyacrylamide gel. The proteins are then transferred to a 
membrane (for example, nitrocellulose) by Western blotting, 
and the antibody preparation is incubated with the mem­
brane. After washing the membrane to remove non-specifi- 
cally bound antibodies, the presence of specifically bound 
antibodies is detected by the use of an anti-mouse antibody 
conjugated to an enzyme such as alkaline phosphatase; 
application of the substrate 5-bromo-4-chloro-3-indolyl 
phosphate/nitro blue tetrazolium results in the production of 
a dense blue compound by immuno-localized alkaline phos­
phatase. Antibodies which specifically detect the PtM3 
protein will, by this technique, be shown to bind to the PtM3 
protein band (which will be localized at a given position on 
the gel determined by its molecular weight). Non-specific 
binding of the antibody to other proteins may occur and may 
be detectable as a weak signal on the Western blot. The 
non-specific nature of this binding will be recognized by one 
skilled in the art by the weak signal obtained on the Western 
blot relative to the strong primary signal arising from the 
specific antibody-PtM3 protein binding.
Substantially pure PtM3 protein suitable for use as an 
immunogen is isolated from rice cells or other cells in which 
it is produced, as described. Concentration of protein in the 
final preparation is adjusted, for example, by concentration 
on an Amicon filter device, to the level of a few micrograms 
per milliliter. Monoclonal or polyclonal antibody to the 
protein can then be prepared as follows:
Monoclonal antibody to epitopes of the PtM3 protein 
identified and isolated as described can be prepared from 
murine hybridomas according to the classical method of 
Kohler and Milstein (1975). Nature 256:495, or derivative 
methods thereof. Briefly, a mouse is repetitively inoculated 
with a few micrograms of the selected protein over a period
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of a few weeks. The mouse is then sacrificed, and the 
antibody-producing cells of the spleen isolated. The spleen 
cells are fused by means of polyethylene glycol with mouse 
myeloma cells, and the excess unfused cells destroyed by 
growth of the system on selective media comprising ami- 
nopterin (HAT media). The successfully fused cells are 
diluted and aliquots of the dilution placed in wells of a 
microtiter plate where growth of the culture is continued. 
Antibody-producing clones are identified by detection of 
antibody in the supernatant fluid of the wells by immunoas­
say procedures, such as ELISA, as originally described by 
Engvall (1980). Enzymol. 70:419, and derivative methods 
thereof. Selected positive clones can be expanded and their 
monoclonal antibody product harvested for use. Detailed 
procedures for monoclonal antibody production are 
described in Harlow and Lane (1988). Antibodies, A Labo­
ratory Manual, Cold Spring Harbor Laboratory, New York.
Polyclonal antiserum containing antibodies to heterog­
enous epitopes of a single protein can be prepared by 
immunizing suitable animals with the expressed protein, 
which can be unmodified or modified to enhance immuno- 
genicity. Effective polyclonal antibody production is 
affected by many factors related both to the antigen and the 
host species. For example, small molecules tend to be less 
immunogenic than others and may require the use of carriers 
and adjuvant. Also, host animals vary in response to site of 
inoculations and dose, with both inadequate or excessive 
doses of antigen resulting in low titer antisera. Small doses 
(ng level) of antigen administered at multiple intradermal 
sites appears to be most reliable. An effective immunization 
protocol for rabbits can be found in Vaitukaitis et al. (1971). 
J. Clin. Endocrinol. Metab. 33:988-991.
Booster injections can be given at regular intervals, and 
antiserum harvested when antibody titer thereof, as deter­
mined semi-quantitatively, for example, by double immun­
odiffusion in agar against known concentrations of the 
antigen, begins to fall. See, for example, Ouchterlony et al. 
(1973). In Handbook o f Experimental Immunology, Wier, D. 
(ed.) chapter 19. Blackwell. Plateau concentration of anti­
body is usually in the range of 0.1 to 0.2 mg/ml of serum. 
Affinity of the antisera for the antigen is determined by 
preparing competitive binding curves, as described, for 
example, by Fisher (1980). Manual o f Clinical Immunology, 
Ch. 42.
A third approach to raising antibodies against the PtM3 
protein is to use synthetic peptides synthesized on a com­
mercially available peptide synthesizer based upon the pre­
dicted amino acid sequence of the PtM3 protein.
Antibodies may be raised against the PtM3 protein by 
subcutaneous injection of a DNA vector which expresses the 
PtM3 protein into laboratory animals, such as mice. Deliv­
ery of the recombinant vector into the animals may be 
achieved using a hand-held form of the Biolistic system as 
described by Tang et al. (1992). Nature (London) 356: 
152-154.
Antibody preparations prepared according to these pro­
tocols are useful in quantitative immunoassays which deter­
mine concentrations of antigen-bearing substances in bio­
logical samples; they are also used semi-quantitatively or 
qualitatively to identify the presence of antigen in a biologi­
cal sample.
The term “in situ hybridization” refers to a number of 
techniques have been developed in which nucleic-acid 
probes are used to locate specific DNA sequences on intact 
chromosomes in situ, a procedure called “in situ hybridiza­
tion.” See, e.g., Pinkel et al., Proc. Natl. Acad. Sci. USA 
85:9138-9142, 1988 (regarding fluorescence in situ hybrid­
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ization), and Lengauer et al., Hum. Mol. Genet. 2:505-512, 
1993 (regarding “chromosomal bar codes”). Well-known 
methods for in situ hybridization and for the preparation of 
probes or primers for such methods are employed in the 
practice of the present invention, including direct and indi­
rect in situ hybridization methods.
All publications cited herein are incorporated by reference 
to the same extent as if each individual publication was 
specifically and individually indicated to be incorporated by 
reference. The invention now being fully described, it will 
be apparent to one of ordinary skill in the art that many 
changes and modifications can be made thereto without 
departing from the spirit or scope of the claims.
The terms used in this specification generally have their 
ordinary meanings in the art, within the context of the 
invention, and in the specific context where each term is 
used. Certain terms are defined above, or elsewhere in the 
specification, to provide additional guidance to the person of 
skill in the art in describing the compositions and methods 
of the invention and how to make and use them. It will be 
appreciated that the same thing can be said in more than one 
way. Consequently, alternative language and synonyms may 
be used for any one or more of the terms discussed herein, 
nor is any special significance to be placed upon whether or 
not a term is elaborated or discussed herein. Synonyms for 
certain terms are provided. A recital of one or more syn­
onyms does not exclude the use of other synonyms. The use 
of examples anywhere in this specification, including 
examples of any terms discussed herein, is illustrative only, 
and in no way limits the scope and meaning of the invention 
or of any exemplified term. Likewise, the invention is not 
limited to the preferred embodiments.
EXAMPLE 1
Use of the Populus cDNAs and Promoters to 
Modify Fertility Characteristics
Once a nucleic acid encoding a protein involved in the 
determination of a particular plant characteristic, such as 
flowering, has been isolated, standard techniques may be 
used to express the nucleic acid in transgenic plants in order 
to modify that particular plant characteristic. One approach 
is to clone the nucleic acid into a vector, such that it is 
operably linked to control sequences (e.g., a promoter) 
which direct expression of the nucleic acid in plant cells. The 
transformation vector is then introduced into plant cells by 
one of a number of techniques (e.g., Agrobacterium-medi­
ated transformation) and progeny plants containing the 
introduced nucleic acid are selected. All or part of the 
transformation vector may stably integrate into the genome 
of the plant cell. That part of the vector which integrates into 
the plant cell and which contains the introduced nucleic acid 
and associated sequences for controlling expression (the 
introduced “transgene”) may be referred to as the transgenic 
expression cassette.
Selection of progeny plants containing the introduced 
transgene may be made based upon the detection of an 
altered phenotype. Such a phenotype may result directly 
from the nucleic acid cloned into the transformation vector 
or may manifest as enhanced resistance to a chemical agent 
(such as an antibiotic) as a result of the inclusion of a 
dominant selectable marker gene incorporated into the trans­
formation vector.
The choice of (a) control sequences and (b) how the 
nucleic acid (or selected portions of the nucleic acid) are 
arranged in the transformation vector relative to the control
30
5
10
15
20
25
30
35
40
45
50
55
60
65
US 7,057,087 B2
sequences determine, in part, how the plant characteristic 
affected by the introduced nucleic acid is modified. For 
example, the control sequences may be tissue specific, such 
that the nucleic acid is only expressed in particular tissues of 
the plant (e.g., reproductive tissues) and so the affected 
characteristic will be modified only in those tissues. The 
nucleic acid sequence may be arranged relative to the 
control sequence such that the nucleic acid transcript is 
expressed normally, or in an antisense orientation. Expres­
sion of an antisense RNA that is the reverse complement of 
the cloned nucleic acid will result in a reduction of the 
targeted gene product (the targeted gene product being the 
protein encoded by the plant gene from which the introduced 
nucleic acid was derived). Over-expression of the intro­
duced nucleic acid, resulting from a plus-sense orientation 
of the nucleic acid relative to the control sequences in the 
vector, may lead to an increase in the level of the gene 
product, or may result in a reduction in the level of the gene 
product due to co-suppression (also termed “sense suppres­
sion”) of that gene product. In another approach, the nucleic 
acid sequence may be modified such that certain domains of 
the encoded peptide are deleted. Depending on the domain 
deleted, such modified nucleic acid may act as dominant 
negative mutations, suppressing the phenotypic effects of 
the corresponding endogenous gene.
Successful examples of the modification of plant charac­
teristics by transformation with cloned nucleic acid 
sequences are replete in the technical and scientific litera­
ture. Selected examples, which serve to illustrate the level of 
knowledge in this field of technology include:
U.S. Pat. No. 5,432,068 (control of male fertility using 
externally inducible promoter sequences);
U.S. Pat. No. 5,686,649 (suppression of plant gene 
expression using processing-defective RNA con­
structs);
U.S. Pat. No. 5,659,124 (transgenic male sterile plants);
U.S. Pat. No. 5,451,514 (modification of lignin synthesis 
using antisense RNA and co-suppression);
U.S. Pat. No. 5,443,974 (modification of saturated and 
unsaturated fatty acid levels using antisense RNA and 
co-suppression);
U.S. Pat. No. 5,530,192 (modification of amino acid and 
fatty acid composition using antisense RNA);
U.S. Pat. No. 5,455,167 (modification of medium chain 
fatty acids)
U.S. Pat. No. 5,231,020 (modification of flavonoids using 
co-suppression);
U.S. Pat. No. 5,583,021 (modification of virus resistance 
by expression of plus-sense RNA); and
Mizukami et al. (1996). Plant Cell 8:831-845 (dominant 
negative mutations in floral development using partial 
deletions of AG).
These examples include descriptions of transformation 
vector selection, transformation techniques and the produc­
tion of constructs designed to over-express an introduced 
nucleic acid, dominant negative mutant forms, untranslat­
able RNA forms or antisense RNA. In light of the foregoing 
and the provision herein of the PtM3 and PtM4 cDNA and 
gene sequences, it is apparent that one of skill in the art may 
be able to introduce these cDNAs or genes, or derivative 
forms of these sequences (e.g., antisense forms), into plants 
in order to produce plants having modified fertility charac­
teristics, particularly sterility. This Example provides a 
description of the approaches that may be used to achieve 
this goal. For convenience, the PtM3 and PtM4 cDNAs and 
genes disclosed herein will be generically referred to as the 
“floral reproductive genes,” and the encoded polypeptides as
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the “floral reproductive gene products” or “floral reproduc­
tive polypeptide”. Example 6 provides an exemplary illus­
tration of how an antisense or inverted repeat form of one of 
these floral reproductive genes, specifically the PTD cDNA, 
may be introduced into angiosperms such as tobacco and 
Arabidopsis using Agrobacterium transformation, in order 
to produce genetically engineered sterile angiosperms. 
Example 5 provides an exemplary illustration of how 
increased expression of PtM3 cDNA may be produced and 
introduced into angiosperm species to produce modified 
fertility characteristics, such as early flowering, increased 
branching, increased flower pod production, and conversion 
of axillary meristems to floral meristems.
a. Vector Construction, Choice of Promoters
A number of recombinant vectors suitable for stable 
transfection of plant cells or for the establishment of trans­
genic plants have been described including those described 
in Pouwels et al. (1987). Cloning Vectors: A Laboratory 
Manual, 1985 supplement; and Weissbach and Weissbach 
(1989). Methods for Plant Molecular Biology, Academic 
Press. Typically, plant transformation vectors include one or 
more cloned plant genes (or cDNAs) under the transcrip­
tional control of 5' and 3' regulatory sequences and a 
dominant selectable marker. Such plant transformation vec­
tors typically also contain a promoter regulatory region (e.g., 
a regulatory region controlling inducible or constitutive, 
environmentally or developmentally regulated, or cell-, tis­
sue-, or temporal-specific expression), a transcription initia­
tion start site, a ribosome binding site, an RNA processing 
signal, a transcription termination site, and/or a polyadeny- 
lation signal.
Examples of plant promoters which may be useful for 
expressing the floral reproductive genes are provided herein 
above.
The promoter regions of the PtM3 or PtM4 gene 
sequences confer floral-specific (or floral-enriched) expres­
sion in Populus. Accordingly, these native promoters may be 
used to obtain floral-specific (or floral-enriched) expression 
of the introduced transgene.
Plant transformation vectors may also include RNA pro­
cessing signals, for example, introns, which may be posi­
tioned upstream or downstream of the ORF sequence in the 
transgene. In addition, the expression vectors may also 
include additional regulatory sequences from the 3'-untrans- 
lated region of plant genes, e.g., a 3' terminator region to 
increase mRNA stability of the mRNA, such as the PI-II 
terminator region of potato or the octopine or nopaline 
synthase 3' terminator regions.
Also, plant transformation vectors may also include domi­
nant selectable marker genes to allow for the ready selection 
of transformants. Such genes include those encoding anti­
biotic resistance genes (e.g., resistance to hygromycin, kana- 
mycin, bleomycin, G418, streptomycin or spectinomycin) 
and herbicide resistance genes (e.g., phosphinothricin 
acetyltransferase).
b. Arrangement of Floral Reproductive Gene Sequence in 
Vector
Modified fertility characteristics in plants may be 
obtained using the floral reproductive gene sequences dis­
closed herein in a variety of forms. Over-expression, sense- 
suppression, antisense RNA, inverted repeats and dominant 
negative mutant forms of the disclosed floral reproductive 
gene sequences may be constructed in order to modulate or 
supplement the expression of the corresponding endogenous 
floral reproductive genes, and thereby to produce plants 
having modified fertility characteristics. Alternatively, the 
floral-specific (or floral-enriched) expression conferred by
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the promoters of the disclosed floral reproductive genes may 
be employed to obtain corresponding expression of cyto­
toxic products. Such constructs will comprise the appropri­
ate floral reproductive promoter sequence operably linked to 
a suitable open reading frame (discussed further below) and 
will be useful in genetic ablation approaches to engineering 
sterility in plants.
i. Modulation/Supplementation of Floral Reproductive 
Gene Expression
The particular arrangement of the floral reproductive gene 
sequence in the transformation vector will be selected 
according to the type of expression of the sequence that is 
desired.
Enhanced expression of a floral reproductive gene may be 
achieved by operably linking the floral reproductive gene to 
a constitutive high-level promoter such as the CaMV 35S 
promoter. As noted below, modified activity of a floral 
reproductive gene product in plants may also be achieved by 
introducing into a plant a transformation vector containing a 
variant form of a floral reproductive gene, for example a 
form which varies from the exact nucleotide sequence of the 
disclosed floral reproductive gene.
A reduction in the activity of a floral reproductive 
polypeptide in the transgenic plant may be obtained by 
introducing into plants antisense constructs based on the 
floral reproductive gene sequence. For expression of anti- 
sense RNA, the floral reproductive gene is arranged in 
reverse orientation relative to the promoter sequence in the 
transformation vector. The introduced sequence need not be 
the full-length floral reproductive gene, and need not be 
exactly homologous to the floral reproductive gene found in 
the plant type to be transformed. Generally, however, where 
the introduced sequence is of shorter length, a higher degree 
of homology to the native floral reproductive gene sequence 
will be needed for effective antisense suppression. Suitably, 
the introduced antisense sequence in the vector will be at 
least 50 nucleotides in length, and improved antisense 
suppression will typically be observed as the length of the 
antisense sequence increases. Suitably, the length of the 
antisense sequence in the vector will be greater than 100 
nucleotides. Transcription of an antisense construct as 
described results in the production of RNA molecules that 
are the reverse complement of mRNA molecules transcribed 
from the endogenous floral reproductive gene in the plant 
cell. Although the exact mechanism by which antisense 
RNA molecules interfere with gene expression has not been 
elucidated, it is believed that antisense RNA molecules bind 
to the endogenous mRNA molecules and thereby inhibit 
translation of the endogenous mRNA.
Suppression of endogenous floral reproductive polypep­
tide activity can also be achieved using ribozymes. 
Ribozymes are synthetic RNA molecules that possess highly 
specific endoribonuclease activity. The production and use 
of ribozymes are disclosed in U.S. Pat. No. 4,987,071 and 
U.S. Pat. No. 5,543,508. The inclusion of ribozyme 
sequences within antisense RNAs may be used to confer 
RNA cleaving activity on the antisense RNA, such that 
endogenous mRNA molecules that bind to the antisense 
RNA are cleaved, which in turn leads to an enhanced 
antisense inhibition of endogenous gene expression.
Constructs in which the floral reproductive gene (or 
variants thereon) are over-expressed may also be used to 
obtain co-suppression of the endogenous floral reproductive 
gene in the manner described in U.S. Pat. No. 5,231,021. 
Such co-suppression (also termed sense suppression) does 
not require that the entire floral reproductive cDNA or gene 
be introduced into the plant cells, nor does it require that the
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introduced sequence be exactly identical to the endogenous 
floral reproductive gene. Flowever, as with antisense sup­
pression, the suppressive efficiency will be enhanced as (1) 
the introduced sequence is lengthened and (2) the sequence 
similarity between the introduced sequence and the endog­
enous floral reproductive gene is increased.
Constructs expressing an untranslatable form of the floral 
reproductive gene mRNA may also be used to suppress the 
expression of endogenous floral reproductive genes. Meth­
ods for producing such constructs are described in U.S. Pat. 
No. 5,583,021. Such constructs are made by introducing a 
premature stop codon into the floral reproductive ORF.
Finally, dominant negative mutant forms of the disclosed 
sequences may be used to block endogenous floral repro­
ductive polypeptide activity using approaches similar to that 
described by Mizukami et al. (1996). Plant Cell 8:831-845.
Such mutants require the production of mutated forms of 
the floral reproductive polypeptide that bind either to an 
endogenous binding target (for example, a nucleic acid 
sequence in the case of floral reproductive polypeptides, 
such as PtM3 and PtM4, that function as transcription 
factors) or to a second polypeptide sequence (such as 
transcription co-factors), but do not function normally after 
such binding (i.e. do not function in the same manner as the 
non-mutated form of the polypeptide). By way of example, 
such dominant mutants can be constructed by deleting all or 
part of the C-terminal domain of a floral reproductive 
polypeptide, leaving an intact MADS domain. Polypeptides 
lacking all or part of the C-terminal region may bind to the 
appropriate DNA target, but are unable to interact with 
protein co-factors, thereby blocking transcription. Alterna­
tively, dominant negative mutants may be produced by 
deleting all or part of the MADS domain, or all or part of the 
K-domain.
ii. Genetic Ablation
An alternative approach to modulating floral development 
is to specifically target a cytotoxic gene product to the floral 
tissues. This may be achieved by producing transgenic 
plants that express a cytotoxic gene product under the 
control of a tissue- and temporal-specific promoter, such as 
the promoter region of PtM3 as disclosed herein. The 
promoter region of this gene sequence is generally contained 
within the first 150 base pairs of sequence upstream of the 
open reading frame, although tissue- and temporal-specific 
expression may be conferred by using smaller regions of this 
sequence. Thus, regions as small as the first 50 base pairs of 
sequence upstream of the open reading frame may be 
effective in conferring tissue- and temporal-specific expres­
sion. Flowever, longer regions, such as at least 100, 150, 200 
or 250 base pairs of the upstream sequences are preferred.
A number of known cytotoxic gene products may be 
expressed under the control of the disclosed promoter 
sequences of the floral reproductive gene. These include: 
RNases, such as barnase from Bacillus amyloliquefaciens 
and RNase-Tl from Aspergillus; Mariani et al. (1992). A 
chimeric ribonuclease-inhibitor gene restores fertility to 
male-sterile plants. Nature 357:384-387; ADP-ribosyl- 
transferase (Diphtheria toxin A chain); Kandasamy et al. 
(1993). Ablation of papillar cell finction in Brassica flowers 
results in the loss of stigma receptivity to pollination. Plant 
Cell 5:263-275; RolC from Agrobacterium rhizogenes; 
Schmulling et al. (1993). Resoration of fertility by antisense 
RNA in genetically engineered male sterile tobacco plants. 
Mol. Gen. Genet. 237-385-394; DTA (diphtheria toxin A); 
Pappenheimer (1977). Diphtheria toxin. Annu. Rev. Bio- 
chem. 46:69-94; and glucanase (Worrall et al. (1992). Pre­
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mature dissolution of the microporocyte callose wall causes 
male sterility in transgenic tobacco. Plant Cell 4:759-771).
c. Transformation and Regeneration Techniques
Constructs designed as discussed above to modulate or
supplement expression of native floral reproductive genes in 
plants, or to express cytotoxins in a tissue- and temporal- 
specific manner can be introduced into plants by a variety of 
means. Transformation and regeneration of both monocoty- 
ledonous and dicotyledonous plant cells is now routine, and 
the selection of the most appropriate transformation tech­
nique will be determined by the practitioner. The choice of 
method will vary with the type of plant to be transformed; 
those skilled in the art will recognize the suitability of 
particular methods for given plant types. Suitable methods 
may include, but are not limited electroporation of plant 
protoplasts; liposome-mediated transformation; polyethyl­
ene mediated transformation; transformation using viruses; 
micro-injection of plant cells; micro-projectile bombard­
ment of plant cells; vacuum infiltration; and Agrobacterium 
tumefaciens (AT) mediated transformation. Typical proce­
dures for transforming and regenerating plants are described 
in the patent documents listed at the beginning of this 
section.
Methods that are particularly suited to the transformation 
of woody species include (for Picea species) methods 
described in Ellis et al. (1993). Bio/Technology 11:84-89; 
and (for Populus species) the use of .4. tumefaciens (Stettler 
(1993). Popular Molecular Network Newsletter 1(1), Col­
lege of Forest Resources AR-10, University of Washington, 
Seattle, Wash.; Strauss et al. (1995a). Molecular Breeding 
1:5-26; Strauss et al. (1995b). TGERC Annual Report: 
1994-1995. Forest Research Laboratory, Oregon State Uni­
versity), A. rhizogenes (Flan et al. (1996). Cellular and 
molecular biology of Agrobacterium-mediated transforma­
tion of plants and its application to genetic transformation of 
Populus. In: Stettler et al. [eds.] Biology of Populus and its 
Implications for Management and Conservation, Part I, 
Chapter 9, pp. 201-222, NRC Research Press, Nat. Res. 
Coun. of Canada, Ottawa, Ontario) and biolistics (McCown 
et al. (1991), stable transformation of Populus and incorpo­
ration of pest resistance by electric discharge particle accel­
eration. Plant Cell Rep. 9:590-594).
d. Selection of Transformed Plants
Following transformation and regeneration of plants with 
the transformation vector, transformed plants are suitably 
selected using a dominant selectable marker incorporated 
into the transformation vector. Typically, such a marker will 
confer antibiotic resistance on the seedlings of transformed 
plants, and selection of transformants can be accomplished 
by exposing the seedlings to appropriate concentrations of 
the antibiotic.
After transformed plants are selected and grown to matu­
rity, the effect on fertility can be determined by visual 
inspection of floral morphology, including the determination 
of the production of pollen or ova. In addition, the effect on 
the activity of the endogenous floral reproductive gene may 
be directly determined by nucleic acid analysis (hybridiza­
tion or PCR methodologies) or immunoassay (western blot) 
of the expressed protein. Antisense or sense suppression of 
the endogenous floral reproductive gene may be detected by 
analyzing mRNA expression on Northern blots or by reverse 
transcription polymerase chain reaction (RT-PCR).
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EXAMPLE 2
Cloning and Sequence Analysis of PtM3 and PtM4 
cDNA
MADS-box cDNA homologs were cloned from male 
(PtM3) and female (PtM4) aspen (Populus tremuloides). 
PtM3 and PtM4 clones were first isolated by Reverse 
transcription-Polymerase chain reaction (RT-PCR) using 
RNA extracted from Populus cells as a template. The gene 
sequences may also be directly amplified using Populus 
genomic DNA as a template. Methods and conditions for 
both direct PCR and RT-PCR are known in the art and are 
described in Innis et al. (1990). PCR Protocols, A Guide to 
Methods and Applications, Innis et al. [eds.], Academic 
Press, Inc., San Diego, Calif. The RT-PCR procedure was 
followed by screening a cDNA library from developing male 
and female aspen flowers (Ausubel et al., 1989. Current 
Protocols, Wiley Publishers, NY). Suitable plant cDNA and 
genomic libraries for direct PCR include Populus libraries 
made by methods described therein. Other tree cDNA and 
genomic libraries may also be screened in order to, amplify 
orthologous cDNAs of tree species, such as Pinus and 
Eucalyptus.
The full-length nucleotide sequences of PTM3 and PTM4 
was obtained by using similar PCR primer sets. One set of 
external PCR primers was used to obtain the PCR product 
and two sets of nested internal PCR primers were used to 
confirm the PCR products obtained from the external prim­
ers. The oligonucleotide sequences of the external primers 
are as follows: 5' primer (cDNA5'Sl)-5' GTTAAG- 
GAATATGGGGAGAGGTAGAGTGG 3' (SEQ ID NO:6) 
and 3' primer (cDNA3'ASb)-5' GTCCCTGGCTAAAGT- 
TCTGAAATCCAGCCAC 3' (SEQ ID NO:7). The 5' inter­
nal set of primers used to confirm the PCR products obtained 
from the external primers are as follows: 5' internal primer 
1 (cDNA5'S2)-5' GATAGAGAACAAGATAAACAG-
GCAGGTGA 3' (SEQ ID NO:8) and 3' internal primer 2 
(FAGL4-ASl)-5' GTTCCTCTGAGTTCGTTGTAGGGC 3' 
(SEQ ID NO:9). The 3' internal set of primers used to 
confirm the PCR products obtained from the external prim­
ers are as follows: 5' internal primer 1 (FAGL4-Sl)-5' 
CAAGATTTGAGGCCCTACAACGA 3' (SEQ ID NO: 10) 
and 3' internal primer 2 (cDNA3'ASb)-5' GTCCCTG- 
GCTAAAGTTCTGAAATCCAGCCAC 3' (SEQ ID 
NO: 11). These primers are illustrative only; it will be 
appreciated by one skilled in the art that many different 
primers may be derived from a cDNA or a full-length gene 
sequence in order to amplify particular regions. Suitable 
amplification conditions for PtM3 and PtM4 include those 
described herein (See, e.g., Innis et al. (1990)). As is well 
known in the art, amplification conditions may nee d to be 
varied in order to amplify orthologous genes where the 
sequence identity is not 100%; in such cases, the use of 
nested primers, as described in (Ausbel 1989) may be 
beneficial. Resequencing of PCR products obtained by these 
amplification procedures is recommended; this will facilitate 
confirmation of the amplified cDNA sequence and will also 
provide information on natural variation on this sequence in 
different ecotypes, cultivars and plant populations.
Oligonucleotides that are derived from the PtM3 or PtM4 
cDNA and gene sequences and which are suitable for use as 
PCR primers to amplify corresponding nucleic acid 
sequences are encompassed within the scope of the present 
invention. Such oligonucleotide primers will comprise a 
sequence of 15-20 consecutive nucleotides of the selected 
cDNA or gene sequence. To enhance amplification speci­
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ficity, primers comprising at least 25, 30, 35, 50 or 100 
consecutive nucleotides of the PtM3 or PtM4 gene or cDNA 
sequences may be used.
The nucleotide sequences of PtM3 and PtM4 cDNAs and 
the PtM3 5' untranslated region containing the promoter 
(See Example 3) were determined using the dideoxy chain 
termination method (Sanger et al., 1977. Proc. Natl. Acad. 
Sci. 74: 5463-5467). FIG. 1 illustrates the polynucleotide 
(SEQ ID NO:l) sequence and the corresponding amino acid 
(SEQ ID NO:4) sequence of Aspen PtM3. FIG. 2 shows the 
polynucleotide (SEQ ID NO:2) sequence and the corre­
sponding amino acid (SEQ ID NO:5) sequence of Aspen 
PtM4. FIG. 3 shows the predicted amino acid sequence 
alignment between Aspen PtM3 and Aspen PtM4, wherein 
the sequence identity between the two homologs is found to 
be 97% using the Clustal W sequence alignment algorithm.
Based on sequence level similarity, it was determined that 
PtM3 and PtM4 belong to the SEP1/2 family of genes, 
which includes AGL2/SEP1, AGL4/SEP2 from Arabidop- 
sis, and DEFF149 from Antirrhinum (Pelaz et al., 2000; 
Angenent et al, 1992; Davies et al., 1996) (FIG. 4). Flow- 
ever, at the amino acid level, it appears that PtM3/PtM4 
share 76% identity with AGL2/SEP1, 75% with AGL4/ 
SEP2, and 68% with DEFF149. Regardless, it should be 
noted that this is the first instance where PtM3 and PtM4 
have been identified to have the same MADS-box family 
gene from the male and female flowers of a dioecious tree 
species. Both, PtM3 and PtM4 were found to be expressed 
during early stages of flower development in aspen and thus 
have potential to control flowering in aspen and other related 
tree species. Furthermore, while the PtM3 and PtM4 
sequences show some similarity to Arabidopsis Sepellata 
genes (See, Pelaz et al) the % sequence identity is not 
enough to classify them as Sepallata group genes.
EXAMPLE 3
PtM3 Promoter Isolation and Sequence Analysis
The promoter region for PtM3 was also cloned. The 
promoter region of PtM3 was isolated using the Genome 
Walker kit purchased from Clontech (Clontech, Calif.). The 
promoter region of PtM3 contained the motifs characteristic 
of MADS-box gene promoters such as CArG boxes as 
determined by searching with the Genomatix software at 
http://www.genomatix.de/mat_fam. (See, GenomatixUSA, 
1776 Mentor Avenue, Cincinnati, Ohio, 45212, USA; Toll- 
Free: (888) 236-3029)
FIG. 5 sets forth the 5'-untranslated region (UTR) which 
includes the polynucleotide sequence of the PtM3 promoter 
along with the intron sequence. The PtM3 promoter contains 
a MADS-box sequence motif from nucleotides 1153 to 
1441, which is believed to regulate gene expression by 
binding to sites, known as CArG boxes, TATA sequences, 
etc., present in the promoter regions of plant MADS-box 
genes (Riechmann et al., Biol. Chem. 378:1079-1101 
(1998). The PtM3 promoter region sequence may be very 
useful in determining how PtM3 related genes are regulated 
in trees and how their expression is modulated during 
dormancy. Promoters from PtM3 or PtM4 may also be 
useful in developing sterile trees through selective inhibition 
of plant reproductive meristems. Since, expression of PtM3 
and PtM4 may be controlled by a tissue and temporal 
specific promoter, constructing DNA constructs or expres­
sion cassettes with the PtM3 promoter may allow for repro­
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ductive tissue targeting and alteration of the timing of gene 
expression of desired genes and gene products as described 
below in Examples 4-6.
EXAMPLE 4
Developmental Regulation and Expression of PtM3
Expression of the antisense transgene was assessed in 
immature plants by extraction of mRNA and Northern 
blotting using the PTD cDNA as a probe, or by RT-PCR. 
Flower specific mRNA expression patterns of PtM3 and 
PtM4 were determined by using sequence specific primers 
followed by RT-PCR of mRNA from various developmental 
stages of aspen male and female flowers. RT-PCR products 
were then blotted and probed with specific DNA probes for 
PtM3 and PtM4. These experiments illustrated that both 
PtM3 and PtM4 were expressed from early stages of devel­
opment and the expression of these genes varied in sexes.
In order to obtain the Northern blot shown in FIG. 6, total 
RNA (10 pg) from each developmental stage of female 
aspen flowers was fractionated on a 1.2% formaldehyde 
agarose gel and transferred to Flybond™ N-nylon mem­
branes (purchased from Amersham). The Northern blot 
membrane was hybridized to 32P-labeled probe at 68° C. and 
washed at high stringency. The specific 3'UTR of PtM3 was 
used as probe. Panel A shows expression of PtM3 mRNA at 
specific flower bud developmental stages, as compared to 
control tissues (leaf and xylem RNA). Panel B shows 
expression of PtM4 mRNA at specific flower bud develop­
mental stages, as compared to control tissues (leaf and 
xylem RNA). Panel C shows the differential expression of 
male PtM3 (M) and female (F) PtM4 floral buds from stage 
4 as compared to leaf (L) and xylem (X) RNA. Panel D 
shows the result of having the 3'-UTR probe of PtM3 used 
to hybridize against total RNA from Stage 4 male and female 
buds. Based on expression patterns of PtM3 and PtM4, it 
appears that these genes are involved in the early stages of 
flower development. PtM3 and PtM4 have great potential to 
alter reproductive capacity of trees both to increase flower­
ing time, and flower numbers and also to develop sterility. 
Also, levels of PtM3 and PtM4 protein were analyzed by 
extraction, purification and concentration of cellular proteins 
to perform in situ hybridization or to make antibodies for 
performing western or blots.
EXAMPLE 5
Phenotypic Alterations in Plants Resulting from 
Over-Expression of PtM3
The altered phenotypes of the transgenic plants over­
expressing PtM3 were analyzed in the panels A-E of FIG. 
7. Panel A, shows tobacco from transgenic line PtM3-21 
(right) showing early flowering as compared to WT tobacco 
(left). This early flowering is a potentially useful trait for 
increased yield by allowing an increase in the number of 
crops per growing season. Additionally, early flowering 
could provide for the production of crops in conditions 
which would not normally generate satisfactory yield to a 
short growing season. Panel B, shows a T1 generation plant 
from one control construct line pTCS5. Panel C, shows a T1 
generation plant from transgenic line PtM3-9-9. Panel D, 
shows a T3 generation transgenic Arabidopsis from line 
PtM3-4-3 (right) displaying increased branching and flower 
pod production as compared to WT (left). Panel E, shows a
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graph depicting the average seed yields (mg) and pod 
numbers in the transgenic PtM3-4-3 plants (right) as com­
pared to WT (left).
The present invention is applicable to many hardwood 
tree species to control flowering including, Populus species, 
cottonwoods, Sweetgum, eucalyptus, fruit trees such as 
apple, peach, nut trees such as walnuts, pecans and almonds. 
Since ectopic over expression of PtM3 in herbaceous plants 
such as Arabidopsis and tobacco caused reduced juvenile 
periods resulting in accelerated and earlier flowering and 
increased fruit production (FIG. 7), it is likely that PtM3 and 
PtM4 can be used for crop plants also to increase seed 
output. Earlier flowering will allow for more rapid selective 
breeding programs for economically important trees. 
Increased branching and flower production will be useful for 
increasing yields of fruit and nut trees and increase flower 
yields for ornamentals. Further experiments have been con­
ducted where the gene constructs containing Aspen PtM3 
have been introduced into Aspen trees to develop over­
expression in transgenic aspen where the juvenile period is 
reduced and flowering is accelerated.
EXAMPLE 6
Phenotypic Alterations in Plants Resulting from 
Suppressed Expression of PtM3
FIG. 8, Panels A-H illustrates the altered phenotypes of 
the transgenic plants with suppressed PtM3 expression. 
Panels A and B show a control plant and a plant with an 
antisense PtM3 incorporated into a plant, respectively. In 
panel A the control is flowering. In panel B, the antisense 
PtM3 tobacco plant is not flowering. In fact the antisense 
PtM3 containing plants mature, begin senescing and even­
tually die without flowering. Panel C shows a transgenic 
tobacco plant containing inverted repeats of a portion of the 
PtM3 sequence which does not form flowers, in comparison 
to the control plants that form normal flowers (panel D). 
Panels E and F show the absence of petals and stamens when 
an inverted repeat of male PtM3 is introduced into the 
bisexual tobacco plant. Only female sex organ is formed and 
can be pollinated by pollen from a control to form pods. 
These results show that the PtM3 may also have a role in the 
male sex determination. Panel G shows flowerless Arabi­
dopsis terminal and Panel H shows normal pod development 
in control.
Antisense or inverted repeat constructs of PtM3 were used 
to suppress gene expression resulting in complete sterility or 
sterility of one of the sex organs in tobacco and Arabidopsis. 
Generating sterile trees for commercial fiber farming of trees 
with value added genes to meet the regulations by USDA, 
EPA, etc. Selective inhibition of either female or male 
organs will have significant use in breeding programs for 
various tree and perennial species. Also, reduced promoter 
activity from PtM3 will be useful in developing sterile trees 
by selective inhibition of reproductive meristems. Also, the 
inhibition of flowering using a PtM3-RNAse cassette or any 
other cytotoxic gene, may have an added benefit by pre­
venting reproductive development at the earliest stage. The 
methods of the present invention result in an advantageous 
energy savings which allows the plant to increase the 
biomass through increased branching because the growing 
conditions are not limiting.
Since aspen is a dioecious tree (sexes are on different 
trees), PtM3 and PtM4 could also be used to control either 
male or female reproductive structures and will be useful for 
breeding. For example, transgenic aspen can be generated
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either to completely abolish flowering (sterility) or to reduce 
juvenile periods and to accelerate flowering so that these 
aspen plants can be used for breeding purposes within 2 
years instead of the normal 6 to 8 years time period. Sterility 
through either using the PtM3 gene promoter controlling a 
cytotoxic RNAse gene or through using constructs with 
antisense or inverted repeat sequences of PtM3 cDNA may 
be very valuable for commercialization of genetically modi­
fied trees. Once the trees are sterilized additional genes with 
other useful traits in the forest products industry such as 
wood quality, rapid growth or pest and herbicide resistance 
can be introduced into the sterile tree. Also, since, trees like 
aspen can be vegetatively propagated, once a transgenic line 
with chosen phenotype is obtained it can be scaled up. The 
methods for generating transgenic aspen are available and 
are developed in our lab (Boerjan et ah, 1997; Kamosky et 
al, 2000; Kim, J. H. 1998; Tsai et al, 1994; 1998).
EXAMPLE 7
Other Applications Using the Disclosed Sequences
The disclosed floral reproductive genes and polypeptides 
may be useful as laboratory reagents to study and analyze 
floral gene expression in plants, including plants engineered 
for modified fertility characteristics. For example, probes 
and primers derived from the PtM3 sequence, as well as 
monoclonal antibodies specific for the PtM3 polypeptide 
may be used to detect and quantify expression of PtM3 in 
seedlings transformed with an antisense PtM3 construct as 
described above. Such analyses would facilitate detection of 
those transformants that display modified PtM3 expression 
and which may therefore be good candidates for having 
modified fertility characteristics.
The production of probes and primers derived from the 
disclosed sequences is described in detail above. Production 
of monoclonal antibodies requires that all or part of the 
protein against which the antibodies to be raised be purified. 
With the provision herein of the floral reproductive gene 
sequences, as well as the sequences of the encoded polypep­
tides, this may be achieved by expression in heterologous 
expression systems, or chemical synthesis of peptide frag­
ments.
Many different expression systems are available for 
expressing cloned nucleic acid molecules. Examples of 
prokaryotic and eukaryotic expression systems that are 
routinely used in laboratories are described in Sambrook et 
al. supra at Ch. 16-17. Such systems maybe used to express 
the floral reproductive polypeptides at high levels to facili­
tate purification.
By way of example only, high level expression of a floral 
reproductive polypeptide may be achieved by cloning and 
expressing the selected cDNA in yeast cells using the 
pYES2 yeast expression vector (Invitrogen, San Diego, 
Calif.). Secretion of the recombinant floral homeotic 
polypeptide from the yeast cells may be achieved by placing 
a yeast signal sequence adjacent to the floral reproductive 
gene coding region. A number of yeast signal sequences 
have been characterized, including the signal sequence for 
yeast invertase. This sequence has been successfully used to 
direct the secretion of heterologous proteins from yeast cells, 
including such proteins as human interferon (Chang et al. 
(1986). Saccharomyces cerevisiae secretes and correctly 
processes human interferon hybrid protein containing yeast 
invertase signal peptides. Mol. and Cell. Biol. 
6:1812-1819.) and human lactoferrin (Liang and Richard­
son (1993). Expression and characterization of human lacto-
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ferrin in yeast (Saccharomyces cerevisiae). J. Agric. Food 
Chem. 41:1800-1807). Alternatively, the enzyme may be 
expressed at high level in prokaryotic expression systems, 
such as in E. coli.
Monoclonal or polyclonal antibodies may be produced to 5 
the selected floral reproductive polypeptide, functionally 
equivalent fragments thereof or portions thereof. Optimally, 
antibodies raised against a specified floral reproductive 
polypeptide will specifically detect that polypeptide. That is, 
for example, antibodies raised against the PtM3 polypeptide to 
would recognize and bind the PtM3 polypeptide and would 
not substantially recognize or bind to other proteins found in 
poplar cells. The determination that an antibody specifically 
detects PtM3 is made by any one of a number of standard 
immunoassay methods; for instance, the Western blotting 15 
technique (Sambrook et al., 1989). To determine that a given 
antibody preparation (such as one produced in a mouse 
against PtM3) specifically detects PtM3 by Western blotting, 
total cellular protein is extracted from poplar cells and 
electrophoresed on a sodium dodecyl sulfate-polyacryla- 20 
mide gel. The proteins are then transferred to a membrane 
(for example, nitrocellulose) by Western blotting, and the 
antibody preparation is incubated with the membrane. After 
washing the membrane to remove non-specifically bound 
antibodies, the presence of specifically bound antibodies is 25 
detected by the use of an anti-mouse antibody conjugated to 
an enzyme such as alkaline phosphatase; application of the 
substrate 5-bromo-4-chloro-3-indolyl phosphate/nitro blue 
tetrazolium results in the production of a dense blue com­
pound by immuno-localized alkaline phosphatase. Antibod- 30 
ies which specifically detect PtM3 will, by this technique, be 
shown to bind to substantially only the PTD band (which 
will be localized at a given position on the gel determined by 
its molecular weight). Non-specific binding of the antibody 
to other proteins may occur and may be detectable as a weak 35 
signal on the Western blot. The non-specific nature of this 
binding will be recognized by one skilled in the art by the 
weak signal obtained on the Western blot relative to the 
strong primary signal arising from the specific antibody- 
PtM3 binding. 40
Substantially pure floral reproductive polypeptides suit­
able for use as an immunogen may be isolated from trans­
formed cells as described above. Concentration of protein in 
the final preparation is adjusted, for example, by concentra­
tion on an Amicon filter device, to the level of a few 45 
micrograms per milliliter. Alternatively, peptide fragments 
of the specified floral reproductive polypeptide may be 
utilized as immunogens. Such fragments may be chemically 
synthesized using standard methods, or may be obtained by 
cleavage of the whole floral reproductive polypeptide fol- 50 
lowed by purification of the desired peptide fragments.
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Peptides as short as 3 or 4 amino acids in length may be 
immunogenic when presented to the immune system in the 
context of a Major Histocompatibility Complex (MHC) 
molecule, such as MHC class I or MHC class II. Accord­
ingly, peptides comprising at least 3 and suitably at least 4, 
5, 6 or 10 or more consecutive amino acids of the disclosed 
floral reproductive polypeptide amino acid sequences may 
be employed as immunogens to raise antibodies. Because 
naturally occurring epitopes on proteins are frequently com­
prised of amino acid residues that are not adjacently 
arranged in the peptide when the peptide sequence is viewed 
as a linear molecule, it may be advantageous to utilize longer 
peptide fragments from the floral reproductive polypeptide 
amino acid sequences in order to raise antibodies. Thus, for 
example, peptides that comprise at least 10, 15, 20, 25 or 30 
consecutive amino acid residues of the floral reproductive 
polypeptide amino acid sequence may be employed. Mono­
clonal or polyclonal antibodies to the intact floral reproduc­
tive polypeptide or peptide fragments of this protein may be 
prepared as described below.
Monoclonal antibody to epitopes of the selected floral 
reproductive polypeptide can be prepared from murine 
hybridomas according to the classical method of Kohler and 
Milstein (1975) or derivative methods thereof. Briefly, a 
mouse is repetitively inoculated with a few micrograms of 
the selected protein over a period of a few weeks. The mouse 
is then sacrificed, and the antibody-producing cells of the 
spleen isolated. The spleen cells are fused by means of 
polyethylene glycol with mouse myeloma cells, and the 
excess unfused cells destroyed by growth of the system on 
selective media comprising aminopterin (HAT media). The 
successfully fused cells are diluted and aliquots of the 
dilution placed in wells of a microtiter plate where growth 
of the culture is continued. Antibody-producing clones may 
be identified by detection of antibody in the supernatant fluid 
of the wells by immunoassay procedures, such as ELISA, as 
originally described by Engvall (1980); and derivative meth­
ods thereof. Selected positive clones can be expanded and 
their monoclonal antibody product harvested for use. 
Detailed procedures for monoclonal antibody production are 
described in Harlow and Lane (1988). Antibodies: A Labo­
ratory Manual, Cold Spring Harbor Laboratory, New York.
Having illustrated and described the principles of isolat­
ing the full-length floral reproductive genes, methods and 
kits for expressing the proteins encoded by these genes to 
obtain a variety of desired phenotypes, it should be apparent 
to one skilled in the art that the invention can be modified in 
arrangement and detail without departing from such prin­
ciples. We claim all modifications coming within the spirit 
and scope of the claims presented herein.
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SEQUENCE LISTING
<160> NUMBER OF SEQ ID NOS: 11
<210> SEQ ID NO 1 
<211> LENGTH: 930 
<212> TYPE: DNA 
<213> ORGANISM: A spen
<400> SEQUENCE: 1
a g a a g a c a a c  c g a a g c a c t t  c t t t a a a c t t  a t a a c t t t c t  c t t t c t a c a a  a c a t t t g t t g 60
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-continued
ttctctctat tattgttaag gaatatgggg agaggtagag tggagotgaa gaggatagag 120
aacaagataa acaggcaggt gacatttgca aagaggagaa atgggttgtt gaagaaagct 180
tatgagttat ctgtgctctg tgatgctgag gttgctctca tcatcttctc taaccgtggc 240
aagctctacg agttttgtag cacatctaac atgctgaaga ccctggaaag gtatcagaag 300
tgcagctatg gtgcagaaga agtcaataaa ccagccaagg agctcgagaa cagctacagg 360
gagtacttga aagtgaaagc aagatttgag ggcctacaac gaactcagag gaaccttctt 420
ggagaggacc tcggacctct gaataccaaa gaccttgagc agctcgagcg tcagttagag 480
tcgtcattga accaagttcg gtcaactaag acccagtata tgctcgacca acttgctgat 540
cttcaaaata aggaacatct gttgcaggaa gctaacagag gtttgacaat aaagctggat 600
gaaatcagtg caagaaatag cctccgacca tcatgggaag gtgatgatca gcaaaatatg 660
tcctacggcc accagcatgc tcagtctcag gggctattcc aggctttgga atgcaatccc 720
actttgcaaa taggctacaa ccctgttggt tcagaccagg tgtctgcaat aacacatgcc 780
acccagcaag tccatgggtt cattccagga tggatgcttt gagttttgtg ctcttcattg 840
ctcataaagg agcacctacc atgtaacttt ctctcttggt gttggtaatg tgtaaatgat 900
ttcaagagca tgtgtacttt catttggaca 930
<210> SEQ ID NO 2 
<211> LENGTH: 914 
<212> TYPE: DNA 
<213> ORGANISM: Aspen 
<220> FEATURE:
<221> NAME/KEY: misc_feature 
<223> OTHER INFORMATION: n = a or• g or c or t/u
<400> SEQUENCE: 2
gtgtggtata tggggagagg tagagtggag ctgaagagga tagaaaacaa aattaatcgg 60
caggtgacat ttgcaaagag gagaaatggg ttgttgaaga aagcttatga gttatctgtg 120
ctctgtgatg ctgaggttgc tctcatcatc ttctctaacc gtggcaagct ctacgagttt 180
tgtagcacat ctaacatgct gaagaccctg gaaaggtatc agaagtgcag ctatggtgca 240
gaagaagtca ataaaccagc caaggagctc gagaacagct acagggagta cttgaaagtg 300
aaagcaagat ttgaggccct acaacgaact cagaggaacc ttcttggaga ggacctcgga 360
cctctgaata ccaaagatct tgagcagctc gagcgtcagt tagagtcgtc attgaaccaa 420
gttcggtcaa ctaagaccca gtatatgctc gaccaacttg ctgatcttca aaataaggaa 480
catctgttgc tggaagctaa cagaggtttg acaataaagc tggatgaaat cagtgcaaga 540
aatagcctcc gaccatcatg ggaaggtgat gatcagcaaa atatgtccta cggncaccag 600
cacgctcagt ctcaggggct attccaggct ttggaatgca atcccacttt gcaaataggc 660
tacaacgctg ttggttcaga ccaggtgtct gcaataacac atgccaccca gcaagtccat 720
gggttcattc caggatggat gctttgagtt ttgtgttctt cattgctcat aaaggagcac 780
ctaccatgta actttctctc ttggtgttgg taatgtgtaa atgatttcaa gagcatgtgt 840
actttcattt ggacatgaaa actttatgtg gctggatttc agaactttag ccagggacac 900
gaggcatgta aaag 914
<210> SEQ ID NO 3 
<211> LENGTH: 1477 
<212> TYPE: DNA 
<213> ORGANISM: Aspen
45
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-continued
<400> SEQUENCE: 3
ggcccggctg gttctcatgt tggactccga ctttaattac tttaactaca agcttattat 60
aatttttttt ttatactatt ttatttcatt tcagtattta aacattattg tttatataaa 120
aaaatagttg agcccgtggc aaagcataaa ccaagaccga atattctaaa tactaaattt 180
ctagtttgtt tgatttctca atgccccgaa cagtaacgct gtaatcagac aacctcatcc 240
ggacaagcca aatcaagaac tttctccagt atcaaaccga cacgtggagg agctccattt 300
taagggaggg gactactttc tgccacgtgt ggaaacatct ggaaatgaca aattgatgcc 360
atataaaatt ttcttacatg aaaggaccac tgtccctttt tacgccccac cgcagcgcgt 420
gaccacactt acaaccctac ctccaacaac actgacacaa tgaccgagac ggtggogogt 480
gaatacactc tccaaactta gaacctacgt tcgtaatcaa tgatgtgaca aaaaagtaaa 540
aaccaagaag ctttgaaagc taataaatga attactatat atattatatc aattcttcaa 600
gaaaattgga agaaattatt ttttttcaat ttaatttata aatataacta tttaatgggg 660
aaagacttct atcctttgga accttaattg gaaaagcagc aaccccatgc cgttaacttg 720
aaaaaaaacg aaacccgggt gtattaaaaa cttaccaaca agggggtaao cttccactaa 780
ccgtgtacaa tggcaaagta acccaactta aggaaaaaga ttccataaat aaaaccattt 840
tcaaaatgta aaatattttt tcaaatattt ataaataact atattaatgt gaaagccatc 900
ataatcccga ttaggagata cttaattagg agaaagtcaa gtcgagaacc cccattgccg 960
ttaatacttg aaaaataaac cagtaaaata cacagaggtt gcatgtaact agaaagaaca 1020
gctaacccta agctgcattt cttttctata tatatatata tatataacag aaaagaagaa 1080
gacaaccgaa gcacttcttt aaacttataa ctttctcttt ctacaaacat ttgttgttct 1140
ctctattatt ggtgggtott tctttctctc tagggtttot ttaaaatatc taactttctc 1200
ttcgtttttc acttattttg ttacagtttg ggttctgatt cctaaaagtg tagatcacct 1260
tcttcttgct cttgagagaa gaacaagaaa cgaaaaaaaa aacaaaagaa aaggaaagat 1320
ataaaggaaa taaagactaa tacaaaagta aatatatcat taacttacat ggttagattt 1380
atgtattaat tataacgaaa gatggttttt tatttggttt tttttggctt gtgattatag 1440
ttaaggaata tggggagagg tagagtggag ctgaaga 1477
<210> SEQ ID NO 4 
<211> LENGTH: 245 
<212> TYPE: PRT 
<213> ORGANISM: Aspen
<400> SEQUENCE: 4
Met Gly Arg Gly Arg Val Glu Leu Lys Arg lie
1 5  10
Glu Asn Lys lie Asn
15
Arg Gin Val Thr Phe Ala Lys Arg Arg Asn Gly
20 25
Leu Leu Lys Lys Ala
30
Tyr Glu Leu Ser Val Leu Cys Asp Ala Glu Val
35 40
Ala Leu lie lie Phe
45
Ser Asn Arg Gly Lys Leu Tyr Glu Phe Cys Ser
50 55
Thr Ser Asn Met Leu
60
Lys Thr Leu Glu Arg Tyr Gin Lys Cys Ser Tyr
65 70 75
Gly Ala Glu Glu Val
80
Asn Lys Pro Ala Lys Glu Leu Glu Asn Ser Tyr Arg Glu Tyr Leu Lys
85 90 95
47
US 7,057,087 B2
48
-continued
Val Lys Ala Arg Phe Glu Gly Leu Gin Arg Thr Gin Arg Asn Leu Leu
100 105 110
Gly Glu Asp Leu Gly Pro Leu Asn Thr Lys Asp Leu Glu Gin Leu Glu
115 120 125
Arg Gin Leu Glu Ser Ser Leu Asn Gin Val Arg Ser Thr Lys Thr Gin
130 135 140
Tyr Met Leu Asp Gin Leu Ala Asp Leu Gin Asn Lys Glu His Leu Leu
145 150 155 160
Gin Glu Ala Asn Arg Gly Leu Thr lie Lys Leu Asp Glu lie Ser Ala
165 170 175
Arg Asn Ser Leu Arg Pro Ser Trp Glu Gly Asp Asp Gin Gin Asn Met
180 185 190
Ser Tyr Gly His Gin His Ala Gin Ser Gin Gly Leu Phe Gin Ala Leu
195 200 205
Glu Cys Asn Pro Thr Leu Gin lie Gly Tyr Asn Pro Val Gly Ser Asp
210 215 220
Gin Val Ser Ala lie Thr His Ala Thr Gin Gin Val His Gly Phe lie
225 230 235 240
Pro Gly Trp Met Leu
245
<210> SEQ ID NO 5 
<211> LENGTH: 245 
<212> TYPE: PRT 
<213> ORGANISM: Aspen
<400> SEQUENCE: 5
Met Gly Arg Gly Arg Val Glu Leu Lys Arg lie Glu Asn Lys lie Asn
1 5 10 15
Arg Gin Val Thr Phe Ala Lys Arg Arg Asn Gly Leu Leu Lys Lys Ala
20 25 30
Tyr Glu Leu Ser Val Leu Cys Asp Ala Glu Val Ala Leu lie lie Phe
35 40 45
Ser Asn Arg Gly Lys Leu Tyr Glu Phe Cys Ser Thr Ser Asn Met Leu
50 55 60
Lys Thr Leu Glu Arg Tyr Gin Lys Cys Ser Tyr Gly Ala Glu Glu Val
65 70 75 80
Asn Lys Pro Ala Lys Glu Leu Glu Asn Ser Tyr Arg Glu Tyr Leu Lys
85 90 95
Val Lys Ala Arg Phe Glu Ala Leu Gin Arg Thr Gin Arg Asn Leu Leu
100 105 110
Gly Glu Asp Leu Gly Pro Leu Asn Thr Lys Asp Leu Glu Gin Leu Glu
115 120 125
Arg Gin Leu Glu Ser Ser Leu Asn Gin Val Arg Ser Thr Lys Thr Gin
130 135 140
Tyr Met Leu Asp Gin Leu Ala Asp Leu Gin Asn Lys Glu His Leu Leu
145 150 155 160
Leu Glu Ala Asn Arg Gly Leu Thr lie Lys Leu Asp Glu lie Ser Ala
165 170 175
Arg Asn Ser Leu Arg Pro Ser Trp Glu Gly Asp Asp Gin Gin Asn Met
180 185 190
Ser Tyr Gly His Gin His Ala Gin Ser Gin Gly Leu Phe Gin Ala Leu
195 200 205
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-continued
Glu Cys Asn Pro Thr Leu Gin lie Gly Tyr Asn Ala Val Gly Ser Asp
210 215 220
Gin Val Ser Ala lie Thr His Ala Thr Gin Gin Val His Gly Phe lie
225 230 235 240
Pro Gly Trp Met Leu 
245
<210> SEQ ID NO 6 
<211> LENGTH: 29 
<212> TYPE: DNA 
<213> ORGANISM: Aspen
<400> SEQUENCE: 6
gttaaggaat atggggagag gtagagtgg 29
<210> SEQ ID NO 7 
<211> LENGTH: 31 
<212> TYPE: DNA 
<213> ORGANISM: Aspen
<400> SEQUENCE: 7
gtccctggct aaagttctga aatccagcca c 31
<210> SEQ ID NO 8 
<211> LENGTH: 29 
<212> TYPE: DNA 
<213> ORGANISM: Aspen
<400> SEQUENCE: 8
gatagagaac aagataaaca ggcaggtga 29
<210> SEQ ID NO 9 
<211> LENGTH: 24 
<212> TYPE: DNA 
<213> ORGANISM: Aspen
<400> SEQUENCE: 9
gttcctctga gttcgttgta gggc 24
<210> SEQ ID NO 10 
<211> LENGTH: 23 
<212> TYPE: DNA 
<213> ORGANISM: Aspen
<400> SEQUENCE: 10
caagatttga ggccctacaa cga 23
<210> SEQ ID NO 11 
<211> LENGTH: 31 
<212> TYPE: DNA 
<213> ORGANISM: Aspen
<400> SEQUENCE: 11
gtccctggct aaagttctga aatccagcca c 31
60
What is claimed is:
1. An isolated polynucleotide encoding a polypeptide, 
wherein the polypeptide comprises SEQ ID NO:4.
2. An isolated polynucleotide comprising the coding 65 
sequence of SEQ ID NO:l, the complement of the coding 
sequence of SEQ ID. NO:l, the reverse complement of the
coding sequence of SEQ ID. NO:l, the full-length reverse 
sequence of the coding sequence of SEQ ID. NO:l, or a 
combination thereof.
3. An isolated polynucleotide comprising:
(a) SEQ ID NO:l
(b) the full-length complement of SEQ ID NO: 1
US 7,057,087 B2
(c) the reverse full-length complement of SEQ ID NO: 1 
or
(d) the reverse full-length sequence of SEQ ID NO:l.
4. An isolated polynucleotide encoding a polypeptide 
having at least 97% amino acid sequence identity to SEQ ID 
NO:4.
5. A construct comprising:
a polynucleotide encoding a polypeptide, wherein the 
polypeptide comprises an amino acid sequence having 
at least 97% identity to SEQ ID NO:4, said polynucle­
otide operably linked to a promoter.
6. An isolated host cell transformed with the construct as 
set forth in claim 5.
7. A transgenic plant comprising at least one construct of 
claim 5.
8. A transgenic tree comprising at least one construct of 
claim 5.
9. A construct as set forth in claim 5, wherein the construct 
further comprises a promoter selected from the group con­
sisting of a constitutive promoter, a tissue-specific promoter, 
a temporal-specific promoter, a developmentally regulated 
promoter, and a combination thereof.
10. A method of altering a characteristic of a plant, 
comprising transforming the plant with the construct as set 
forth in claim 5, wherein the altered characteristic is selected 
from the group consisting of accelerated flowering time, 
increased flowering number, increased fruit production, 
increased nut production, increased seed output, increased 
branching, conversion of axillary meristems to floral mer- 
istems, increased reproductive capacity of sex organs, early 
reproductive development, and combinations thereof com­
pared to a control plant that is not transformed with the 
construct.
11. The method as set forth in claim 10, wherein the plant 
exhibits increased biomass.
12. A method of producing a transgenic plant having at 
least one altered characteristic compared to a nontransgenic 
control plant, wherein the method comprises:
(a) introducing into a plant cell a polynucleotide encoding 
a polypeptide comprising SEQ ID NO:4, to yield a 
transformed cell; and
(b) generating the transgenic plant from the transformed 
cell, the plant having at least one altered characteristic 
selected from the group consisting of (i) axillary mer- 
istem converted to floral meristem; (ii) accelerated 
flowering; (iii) early reproductive development; (iv) 
increased fruit production; (v) earlier flowering times; 
(vi) increased seed output; (vii) increased branching; 
(viii) increased flower production; (ix) increased fruit 
yield; and (x) increased flower yields.
13. The method as set forth in claim 12, wherein the plant 
is selected from the group consisting of a herbaceous plant, 
a crop plant, a perennial plant, a hybrid plant, a seed plant, 
a flowering plant, a tobacco plant, and an Arabidopsis plant.
14. The method as set forth in claim 12, wherein the plant 
is a tree.
15. The method as set forth in claim 14, wherein the tree 
includes at least one of a dioecious tree, a hybrid tree, a 
bisexual tree, a hardwood tree, or a Populus tree.
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16. The method as set forth in claim 14, wherein the tree 
is Aspen.
17. The method of altering the reproductive capacity of a 
plant comprising:
(a) stably transforming a plant cell with the construct of 
claim 5, wherein the polynucleotide is incorporated in 
the genome of the plant cell; and
(b) growing the plant cell to produce a regenerated plant 
capable of expressing a polypeptide encoded by the 
polynucleotide for a time sufficient to alter the repro­
ductive capacity of the plant.
18. The method as set forth in claim 17, wherein the 
polypeptide is over-expressed.
19. A method of ectopically expressing a polypeptide 
encoded by a floral reproductive gene in a plant, comprising 
introducing into the genome of the plant the construct of 
claim 5.
20. A method of producing a transgenic plant having 
altered reproductive capacity compared to a nontransgenic 
control plant, the method comprising:
(a) introducing into a plant cell a polynucleotide encoding 
a polypeptide comprising SEQ ID NO:4 to yield a 
transformed cell;
(b) generating a transgenic plant from the transformed 
cell, wherein the plant has altered reproductive capac­
ity.
21. The method as set forth in claim 20, wherein the plant 
is selected from the group consisting of a herbaceous plant, 
a crop plant, a perennial plant, a hybrid plant, a seed plant, 
a flowering plant, a tobacco plant, and an Arabidopsis plant.
22. The method as set forth in claim 20, wherein the plant 
is a tree.
23. The method as set forth in claim 22, wherein the tree 
is selected from the group consisting of a dioecious tree, a 
hybrid tree, a bisexual tree, a hardwood tree, and a Populus 
tree.
24. The method as set forth in claim 22, wherein the tree 
is Aspen.
25. The method as set forth in claim 20, further compris­
ing introducing an additional exogenous nucleotide 
sequence into the genome of the plant, wherein a polypep­
tide encoded by the additional exogenous nucleotide 
sequence is expressed in the plant, such that the plant 
exhibits increased herbicide resistance.
26. The method as set forth in claim 20, wherein the 
altered plant characteristic is selected front the group con­
sisting of increased plant biomass, reduced pollen produc­
tion and combinations thereof.
27. A plant produced by the method of claim 12.
28. A plant produced by the method of claim 17.
29. A plant produced by the method of claim 19.
30. A plant produced by the method of claim 20.
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